CN111411098A - Rice A L S mutant gene, plant transgenic screening vector pCA L Sm2 containing gene and application thereof - Google Patents
Rice A L S mutant gene, plant transgenic screening vector pCA L Sm2 containing gene and application thereof Download PDFInfo
- Publication number
- CN111411098A CN111411098A CN202010379281.1A CN202010379281A CN111411098A CN 111411098 A CN111411098 A CN 111411098A CN 202010379281 A CN202010379281 A CN 202010379281A CN 111411098 A CN111411098 A CN 111411098A
- Authority
- CN
- China
- Prior art keywords
- plant
- screening
- genetic transformation
- rice
- bispyribac
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012216 screening Methods 0.000 title claims abstract description 121
- 230000009261 transgenic effect Effects 0.000 title claims abstract description 97
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 48
- 239000013598 vector Substances 0.000 title claims abstract description 44
- 108700001094 Plant Genes Proteins 0.000 title description 4
- 241000196324 Embryophyta Species 0.000 claims abstract description 148
- 230000002068 genetic effect Effects 0.000 claims abstract description 103
- 230000009466 transformation Effects 0.000 claims abstract description 102
- 206010020649 Hyperkeratosis Diseases 0.000 claims abstract description 67
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 65
- 235000009566 rice Nutrition 0.000 claims abstract description 65
- 230000014509 gene expression Effects 0.000 claims abstract description 51
- 239000004009 herbicide Substances 0.000 claims abstract description 45
- 108010021466 Mutant Proteins Proteins 0.000 claims abstract description 21
- 102000008300 Mutant Proteins Human genes 0.000 claims abstract description 21
- 239000003550 marker Substances 0.000 claims abstract description 15
- 241000209094 Oryza Species 0.000 claims abstract 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 5
- FUHMZYWBSHTEDZ-UHFFFAOYSA-M bispyribac-sodium Chemical compound [Na+].COC1=CC(OC)=NC(OC=2C(=C(OC=3N=C(OC)C=C(OC)N=3)C=CC=2)C([O-])=O)=N1 FUHMZYWBSHTEDZ-UHFFFAOYSA-M 0.000 claims description 87
- XVOKUMIPKHGGTN-UHFFFAOYSA-N Imazethapyr Chemical compound OC(=O)C1=CC(CC)=CN=C1C1=NC(C)(C(C)C)C(=O)N1 XVOKUMIPKHGGTN-UHFFFAOYSA-N 0.000 claims description 77
- 230000004069 differentiation Effects 0.000 claims description 77
- 239000002609 medium Substances 0.000 claims description 45
- 239000001963 growth medium Substances 0.000 claims description 39
- 230000002363 herbicidal effect Effects 0.000 claims description 28
- 239000012883 rooting culture medium Substances 0.000 claims description 18
- 239000012882 rooting medium Substances 0.000 claims description 18
- 150000001413 amino acids Chemical class 0.000 claims description 13
- 239000003112 inhibitor Substances 0.000 claims description 11
- 108700019146 Transgenes Proteins 0.000 claims description 9
- 150000007523 nucleic acids Chemical class 0.000 claims description 9
- 239000002773 nucleotide Substances 0.000 claims description 9
- 125000003729 nucleotide group Chemical group 0.000 claims description 9
- 101150010882 S gene Proteins 0.000 claims description 8
- 108020004707 nucleic acids Proteins 0.000 claims description 8
- 102000039446 nucleic acids Human genes 0.000 claims description 8
- 102100031673 Corneodesmosin Human genes 0.000 claims description 7
- 101710139375 Corneodesmosin Proteins 0.000 claims description 7
- 238000010367 cloning Methods 0.000 claims description 7
- 239000013604 expression vector Substances 0.000 claims description 6
- 230000035772 mutation Effects 0.000 claims description 6
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- 238000010276 construction Methods 0.000 claims description 5
- 230000006872 improvement Effects 0.000 claims description 5
- 239000012620 biological material Substances 0.000 claims description 4
- 238000013518 transcription Methods 0.000 claims description 4
- 230000035897 transcription Effects 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 230000000977 initiatory effect Effects 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 102000007469 Actins Human genes 0.000 claims description 2
- 108010085238 Actins Proteins 0.000 claims description 2
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 claims description 2
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 abstract description 11
- QTJCKLQRJJTCIS-UHFFFAOYSA-N 2-hydroxybenzoic acid;pyrimidine Chemical compound C1=CN=CN=C1.OC(=O)C1=CC=CC=C1O QTJCKLQRJJTCIS-UHFFFAOYSA-N 0.000 abstract description 6
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 108700026220 vif Genes Proteins 0.000 abstract description 3
- CLQMBPJKHLGMQK-UHFFFAOYSA-N 2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)nicotinic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=NC=CC=C1C(O)=O CLQMBPJKHLGMQK-UHFFFAOYSA-N 0.000 description 69
- 229930006000 Sucrose Natural products 0.000 description 61
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 61
- 239000005720 sucrose Substances 0.000 description 61
- 240000007594 Oryza sativa Species 0.000 description 60
- 229920002148 Gellan gum Polymers 0.000 description 59
- RMOGWMIKYWRTKW-UONOGXRCSA-N (S,S)-paclobutrazol Chemical compound C([C@@H]([C@@H](O)C(C)(C)C)N1N=CN=C1)C1=CC=C(Cl)C=C1 RMOGWMIKYWRTKW-UONOGXRCSA-N 0.000 description 27
- 239000005985 Paclobutrazol Substances 0.000 description 27
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 24
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 24
- 229960001669 kinetin Drugs 0.000 description 24
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 23
- 239000000600 sorbitol Substances 0.000 description 23
- 241000589158 Agrobacterium Species 0.000 description 21
- 108020004414 DNA Proteins 0.000 description 20
- 239000000047 product Substances 0.000 description 15
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 14
- 239000012634 fragment Substances 0.000 description 14
- 238000003752 polymerase chain reaction Methods 0.000 description 14
- 238000005507 spraying Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 239000005484 Bifenox Substances 0.000 description 10
- SUSRORUBZHMPCO-UHFFFAOYSA-N MC-4379 Chemical compound C1=C([N+]([O-])=O)C(C(=O)OC)=CC(OC=2C(=CC(Cl)=CC=2)Cl)=C1 SUSRORUBZHMPCO-UHFFFAOYSA-N 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000001131 transforming effect Effects 0.000 description 8
- 239000005488 Bispyribac Substances 0.000 description 7
- RYVIXQCRCQLFCM-UHFFFAOYSA-N bispyribac Chemical compound COC1=CC(OC)=NC(OC=2C(=C(OC=3N=C(OC)C=C(OC)N=3)C=CC=2)C(O)=O)=N1 RYVIXQCRCQLFCM-UHFFFAOYSA-N 0.000 description 7
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 7
- 230000001404 mediated effect Effects 0.000 description 7
- 238000011426 transformation method Methods 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 229940100389 Sulfonylurea Drugs 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
- 244000062793 Sorghum vulgare Species 0.000 description 4
- 239000005018 casein Substances 0.000 description 4
- 235000021240 caseins Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 229940124530 sulfonamide Drugs 0.000 description 4
- 150000003456 sulfonamides Chemical class 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- 240000008467 Oryza sativa Japonica Group Species 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 108010049041 glutamylalanine Proteins 0.000 description 3
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- TXVINPWAWOEHRS-UHFFFAOYSA-N pyrimidin-2-yl 2-hydroxybenzoate Chemical compound OC1=CC=CC=C1C(=O)OC1=NC=CC=N1 TXVINPWAWOEHRS-UHFFFAOYSA-N 0.000 description 3
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 108010000700 Acetolactate synthase Proteins 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 244000299507 Gossypium hirsutum Species 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- YDTUEBLEAVANFH-RCWTZXSCSA-N Pro-Val-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 YDTUEBLEAVANFH-RCWTZXSCSA-N 0.000 description 2
- 108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 description 2
- 102100027773 Pulmonary surfactant-associated protein A2 Human genes 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- 239000012881 co-culture medium Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 102000034287 fluorescent proteins Human genes 0.000 description 2
- 108091006047 fluorescent proteins Proteins 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- 235000014393 valine Nutrition 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JNTMAZFVYNDPLB-PEDHHIEDSA-N (2S,3S)-2-[[[(2S)-1-[(2S,3S)-2-amino-3-methyl-1-oxopentyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-methylpentanoic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JNTMAZFVYNDPLB-PEDHHIEDSA-N 0.000 description 1
- PKOHVHWNGUHYRE-ZFWWWQNUSA-N (2s)-1-[2-[[(2s)-2-amino-3-(1h-indol-3-yl)propanoyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound O=C([C@H](CC=1C2=CC=CC=C2NC=1)N)NCC(=O)N1CCC[C@H]1C(O)=O PKOHVHWNGUHYRE-ZFWWWQNUSA-N 0.000 description 1
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 1
- XCVRVWZTXPCYJT-BIIVOSGPSA-N Ala-Asn-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N XCVRVWZTXPCYJT-BIIVOSGPSA-N 0.000 description 1
- GWFSQQNGMPGBEF-GHCJXIJMSA-N Ala-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N GWFSQQNGMPGBEF-GHCJXIJMSA-N 0.000 description 1
- VBRDBGCROKWTPV-XHNCKOQMSA-N Ala-Glu-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N VBRDBGCROKWTPV-XHNCKOQMSA-N 0.000 description 1
- LXAARTARZJJCMB-CIQUZCHMSA-N Ala-Ile-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LXAARTARZJJCMB-CIQUZCHMSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- XRUJOVRWNMBAAA-NHCYSSNCSA-N Ala-Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 XRUJOVRWNMBAAA-NHCYSSNCSA-N 0.000 description 1
- JAQNUEWEJWBVAY-WBAXXEDZSA-N Ala-Phe-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 JAQNUEWEJWBVAY-WBAXXEDZSA-N 0.000 description 1
- RTZCUEHYUQZIDE-WHFBIAKZSA-N Ala-Ser-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RTZCUEHYUQZIDE-WHFBIAKZSA-N 0.000 description 1
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 description 1
- UBTKNYUAMYRMKE-GOPGUHFVSA-N Ala-Trp-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CN=CN3)C(=O)O)N UBTKNYUAMYRMKE-GOPGUHFVSA-N 0.000 description 1
- IYKVSFNGSWTTNZ-GUBZILKMSA-N Ala-Val-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IYKVSFNGSWTTNZ-GUBZILKMSA-N 0.000 description 1
- NLYYHIKRBRMAJV-AEJSXWLSSA-N Ala-Val-Pro Chemical compound C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N NLYYHIKRBRMAJV-AEJSXWLSSA-N 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- YFWTXMRJJDNTLM-LSJOCFKGSA-N Arg-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YFWTXMRJJDNTLM-LSJOCFKGSA-N 0.000 description 1
- VBFJESQBIWCWRL-DCAQKATOSA-N Arg-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VBFJESQBIWCWRL-DCAQKATOSA-N 0.000 description 1
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 1
- SKTGPBFTMNLIHQ-KKUMJFAQSA-N Arg-Glu-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SKTGPBFTMNLIHQ-KKUMJFAQSA-N 0.000 description 1
- JTZUZBADHGISJD-SRVKXCTJSA-N Arg-His-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O JTZUZBADHGISJD-SRVKXCTJSA-N 0.000 description 1
- NMRHDSAOIURTNT-RWMBFGLXSA-N Arg-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N NMRHDSAOIURTNT-RWMBFGLXSA-N 0.000 description 1
- NGTYEHIRESTSRX-UWVGGRQHSA-N Arg-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N NGTYEHIRESTSRX-UWVGGRQHSA-N 0.000 description 1
- OISWSORSLQOGFV-AVGNSLFASA-N Arg-Met-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CCCN=C(N)N OISWSORSLQOGFV-AVGNSLFASA-N 0.000 description 1
- UIUXXFIKWQVMEX-UFYCRDLUSA-N Arg-Phe-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O UIUXXFIKWQVMEX-UFYCRDLUSA-N 0.000 description 1
- WKPXXXUSUHAXDE-SRVKXCTJSA-N Arg-Pro-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O WKPXXXUSUHAXDE-SRVKXCTJSA-N 0.000 description 1
- 108010051330 Arg-Pro-Gly-Pro Proteins 0.000 description 1
- ICRHGPYYXMWHIE-LPEHRKFASA-N Arg-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O ICRHGPYYXMWHIE-LPEHRKFASA-N 0.000 description 1
- LOVIQNMIPQVIGT-BVSLBCMMSA-N Arg-Trp-Phe Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCCN=C(N)N)N)C(O)=O)C1=CC=CC=C1 LOVIQNMIPQVIGT-BVSLBCMMSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- RCENDENBBJFJHZ-ACZMJKKPSA-N Asn-Asn-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O RCENDENBBJFJHZ-ACZMJKKPSA-N 0.000 description 1
- LTZIRYMWOJHRCH-GUDRVLHUSA-N Asn-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N LTZIRYMWOJHRCH-GUDRVLHUSA-N 0.000 description 1
- JLNFZLNDHONLND-GARJFASQSA-N Asn-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N JLNFZLNDHONLND-GARJFASQSA-N 0.000 description 1
- LZLCLRQMUQWUHJ-GUBZILKMSA-N Asn-Lys-Gln Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N LZLCLRQMUQWUHJ-GUBZILKMSA-N 0.000 description 1
- ZJIFRAPZHAGLGR-MELADBBJSA-N Asn-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)N)N)C(=O)O ZJIFRAPZHAGLGR-MELADBBJSA-N 0.000 description 1
- YUOXLJYVSZYPBJ-CIUDSAMLSA-N Asn-Pro-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O YUOXLJYVSZYPBJ-CIUDSAMLSA-N 0.000 description 1
- PDECQIHABNQRHN-GUBZILKMSA-N Asp-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O PDECQIHABNQRHN-GUBZILKMSA-N 0.000 description 1
- WBDWQKRLTVCDSY-WHFBIAKZSA-N Asp-Gly-Asp Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O WBDWQKRLTVCDSY-WHFBIAKZSA-N 0.000 description 1
- TZOZNVLBTAFJRW-UGYAYLCHSA-N Asp-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N TZOZNVLBTAFJRW-UGYAYLCHSA-N 0.000 description 1
- QNFRBNZGVVKBNJ-PEFMBERDSA-N Asp-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N QNFRBNZGVVKBNJ-PEFMBERDSA-N 0.000 description 1
- RPUYTJJZXQBWDT-SRVKXCTJSA-N Asp-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N RPUYTJJZXQBWDT-SRVKXCTJSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005472 Bensulfuron methyl Substances 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 208000003643 Callosities Diseases 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 239000005496 Chlorsulfuron Substances 0.000 description 1
- ZEXHDOQQYZKOIB-ACZMJKKPSA-N Cys-Glu-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZEXHDOQQYZKOIB-ACZMJKKPSA-N 0.000 description 1
- UXIYYUMGFNSGBK-XPUUQOCRSA-N Cys-Gly-Val Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O UXIYYUMGFNSGBK-XPUUQOCRSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- RGRMOYQUIJVQQD-SRVKXCTJSA-N Gln-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)N)N RGRMOYQUIJVQQD-SRVKXCTJSA-N 0.000 description 1
- MADFVRSKEIEZHZ-DCAQKATOSA-N Gln-Gln-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N MADFVRSKEIEZHZ-DCAQKATOSA-N 0.000 description 1
- GHYJGDCPHMSFEJ-GUBZILKMSA-N Gln-Gln-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N GHYJGDCPHMSFEJ-GUBZILKMSA-N 0.000 description 1
- RBWKVOSARCFSQQ-FXQIFTODSA-N Gln-Gln-Ser Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O RBWKVOSARCFSQQ-FXQIFTODSA-N 0.000 description 1
- MFJAPSYJQJCQDN-BQBZGAKWSA-N Gln-Gly-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O MFJAPSYJQJCQDN-BQBZGAKWSA-N 0.000 description 1
- PODFFOWWLUPNMN-DCAQKATOSA-N Gln-His-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(O)=O PODFFOWWLUPNMN-DCAQKATOSA-N 0.000 description 1
- IIMZHVKZBGSEKZ-SZMVWBNQSA-N Gln-Trp-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(O)=O IIMZHVKZBGSEKZ-SZMVWBNQSA-N 0.000 description 1
- WTJIWXMJESRHMM-XDTLVQLUSA-N Gln-Tyr-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O WTJIWXMJESRHMM-XDTLVQLUSA-N 0.000 description 1
- HPBKQFJXDUVNQV-FHWLQOOXSA-N Gln-Tyr-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O HPBKQFJXDUVNQV-FHWLQOOXSA-N 0.000 description 1
- RLZBLVSJDFHDBL-KBIXCLLPSA-N Glu-Ala-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RLZBLVSJDFHDBL-KBIXCLLPSA-N 0.000 description 1
- ZPASCJBSSCRWMC-GVXVVHGQSA-N Glu-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N ZPASCJBSSCRWMC-GVXVVHGQSA-N 0.000 description 1
- KRRFFAHEAOCBCQ-SIUGBPQLSA-N Glu-Ile-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KRRFFAHEAOCBCQ-SIUGBPQLSA-N 0.000 description 1
- PJBVXVBTTFZPHJ-GUBZILKMSA-N Glu-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N PJBVXVBTTFZPHJ-GUBZILKMSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- KKBWDNZXYLGJEY-UHFFFAOYSA-N Gly-Arg-Pro Natural products NCC(=O)NC(CCNC(=N)N)C(=O)N1CCCC1C(=O)O KKBWDNZXYLGJEY-UHFFFAOYSA-N 0.000 description 1
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 1
- QPDUVFSVVAOUHE-XVKPBYJWSA-N Gly-Gln-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CN)C(O)=O QPDUVFSVVAOUHE-XVKPBYJWSA-N 0.000 description 1
- SOEATRRYCIPEHA-BQBZGAKWSA-N Gly-Glu-Glu Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SOEATRRYCIPEHA-BQBZGAKWSA-N 0.000 description 1
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 1
- IDOGEHIWMJMAHT-BYPYZUCNSA-N Gly-Gly-Cys Chemical compound NCC(=O)NCC(=O)N[C@@H](CS)C(O)=O IDOGEHIWMJMAHT-BYPYZUCNSA-N 0.000 description 1
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 1
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 1
- RVGMVLVBDRQVKB-UWVGGRQHSA-N Gly-Met-His Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN RVGMVLVBDRQVKB-UWVGGRQHSA-N 0.000 description 1
- BMWFDYIYBAFROD-WPRPVWTQSA-N Gly-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN BMWFDYIYBAFROD-WPRPVWTQSA-N 0.000 description 1
- CUVBTVWFVIIDOC-YEPSODPASA-N Gly-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CN CUVBTVWFVIIDOC-YEPSODPASA-N 0.000 description 1
- DKJWUIYLMLUBDX-XPUUQOCRSA-N Gly-Val-Cys Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)O DKJWUIYLMLUBDX-XPUUQOCRSA-N 0.000 description 1
- RYAOJUMWLWUGNW-QMMMGPOBSA-N Gly-Val-Gly Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O RYAOJUMWLWUGNW-QMMMGPOBSA-N 0.000 description 1
- AFMOTCMSEBITOE-YEPSODPASA-N Gly-Val-Thr Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AFMOTCMSEBITOE-YEPSODPASA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- AIPUZFXMXAHZKY-QWRGUYRKSA-N His-Leu-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O AIPUZFXMXAHZKY-QWRGUYRKSA-N 0.000 description 1
- ZSKJIISDJXJQPV-BZSNNMDCSA-N His-Leu-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CN=CN1 ZSKJIISDJXJQPV-BZSNNMDCSA-N 0.000 description 1
- FFYYUUWROYYKFY-IHRRRGAJSA-N His-Val-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O FFYYUUWROYYKFY-IHRRRGAJSA-N 0.000 description 1
- CYHYBSGMHMHKOA-CIQUZCHMSA-N Ile-Ala-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N CYHYBSGMHMHKOA-CIQUZCHMSA-N 0.000 description 1
- NKRJALPCDNXULF-BYULHYEWSA-N Ile-Asp-Gly Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O NKRJALPCDNXULF-BYULHYEWSA-N 0.000 description 1
- HOLOYAZCIHDQNS-YVNDNENWSA-N Ile-Gln-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HOLOYAZCIHDQNS-YVNDNENWSA-N 0.000 description 1
- DVRDRICMWUSCBN-UKJIMTQDSA-N Ile-Gln-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N DVRDRICMWUSCBN-UKJIMTQDSA-N 0.000 description 1
- WZDCVAWMBUNDDY-KBIXCLLPSA-N Ile-Glu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O)N WZDCVAWMBUNDDY-KBIXCLLPSA-N 0.000 description 1
- PDTMWFVVNZYWTR-NHCYSSNCSA-N Ile-Gly-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O PDTMWFVVNZYWTR-NHCYSSNCSA-N 0.000 description 1
- HYLIOBDWPQNLKI-HVTMNAMFSA-N Ile-His-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N HYLIOBDWPQNLKI-HVTMNAMFSA-N 0.000 description 1
- QZZIBQZLWBOOJH-PEDHHIEDSA-N Ile-Ile-Val Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)O QZZIBQZLWBOOJH-PEDHHIEDSA-N 0.000 description 1
- NLZVTPYXYXMCIP-XUXIUFHCSA-N Ile-Pro-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O NLZVTPYXYXMCIP-XUXIUFHCSA-N 0.000 description 1
- FQYQMFCIJNWDQZ-CYDGBPFRSA-N Ile-Pro-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 FQYQMFCIJNWDQZ-CYDGBPFRSA-N 0.000 description 1
- JCGMFFQQHJQASB-PYJNHQTQSA-N Ile-Val-His Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O JCGMFFQQHJQASB-PYJNHQTQSA-N 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- IBMVEYRWAWIOTN-UHFFFAOYSA-N L-Leucyl-L-Arginyl-L-Proline Natural products CC(C)CC(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O IBMVEYRWAWIOTN-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 1
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 1
- RVVBWTWPNFDYBE-SRVKXCTJSA-N Leu-Glu-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVVBWTWPNFDYBE-SRVKXCTJSA-N 0.000 description 1
- HFBCHNRFRYLZNV-GUBZILKMSA-N Leu-Glu-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HFBCHNRFRYLZNV-GUBZILKMSA-N 0.000 description 1
- KVMULWOHPPMHHE-DCAQKATOSA-N Leu-Glu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KVMULWOHPPMHHE-DCAQKATOSA-N 0.000 description 1
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 1
- PDQDCFBVYXEFSD-SRVKXCTJSA-N Leu-Leu-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PDQDCFBVYXEFSD-SRVKXCTJSA-N 0.000 description 1
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 1
- QONKWXNJRRNTBV-AVGNSLFASA-N Leu-Pro-Met Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)O)N QONKWXNJRRNTBV-AVGNSLFASA-N 0.000 description 1
- CGHXMODRYJISSK-NHCYSSNCSA-N Leu-Val-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O CGHXMODRYJISSK-NHCYSSNCSA-N 0.000 description 1
- AIMGJYMCTAABEN-GVXVVHGQSA-N Leu-Val-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIMGJYMCTAABEN-GVXVVHGQSA-N 0.000 description 1
- AAKRWBIIGKPOKQ-ONGXEEELSA-N Leu-Val-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AAKRWBIIGKPOKQ-ONGXEEELSA-N 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- MPOHDJKRBLVGCT-CIUDSAMLSA-N Lys-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N MPOHDJKRBLVGCT-CIUDSAMLSA-N 0.000 description 1
- MKBIVWXCFINCLE-SRVKXCTJSA-N Lys-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N MKBIVWXCFINCLE-SRVKXCTJSA-N 0.000 description 1
- PBLLTSKBTAHDNA-KBPBESRZSA-N Lys-Gly-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PBLLTSKBTAHDNA-KBPBESRZSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- LQMHZERGCQJKAH-STQMWFEESA-N Met-Gly-Phe Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 LQMHZERGCQJKAH-STQMWFEESA-N 0.000 description 1
- GETCJHFFECHWHI-QXEWZRGKSA-N Met-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCSC)N GETCJHFFECHWHI-QXEWZRGKSA-N 0.000 description 1
- WPTDJKDGICUFCP-XUXIUFHCSA-N Met-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCSC)N WPTDJKDGICUFCP-XUXIUFHCSA-N 0.000 description 1
- QAVZUKIPOMBLMC-AVGNSLFASA-N Met-Val-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(C)C QAVZUKIPOMBLMC-AVGNSLFASA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 240000002582 Oryza sativa Indica Group Species 0.000 description 1
- UHRNIXJAGGLKHP-DLOVCJGASA-N Phe-Ala-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O UHRNIXJAGGLKHP-DLOVCJGASA-N 0.000 description 1
- NOFBJKKOPKJDCO-KKXDTOCCSA-N Phe-Ala-Tyr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NOFBJKKOPKJDCO-KKXDTOCCSA-N 0.000 description 1
- UNLYPPYNDXHGDG-IHRRRGAJSA-N Phe-Gln-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 UNLYPPYNDXHGDG-IHRRRGAJSA-N 0.000 description 1
- OQTDZEJJWWAGJT-KKUMJFAQSA-N Phe-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O OQTDZEJJWWAGJT-KKUMJFAQSA-N 0.000 description 1
- IWNOFCGBMSFTBC-CIUDSAMLSA-N Pro-Ala-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IWNOFCGBMSFTBC-CIUDSAMLSA-N 0.000 description 1
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 1
- HFZNNDWPHBRNPV-KZVJFYERSA-N Pro-Ala-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HFZNNDWPHBRNPV-KZVJFYERSA-N 0.000 description 1
- LNLNHXIQPGKRJQ-SRVKXCTJSA-N Pro-Arg-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1 LNLNHXIQPGKRJQ-SRVKXCTJSA-N 0.000 description 1
- HXOLCSYHGRNXJJ-IHRRRGAJSA-N Pro-Asp-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HXOLCSYHGRNXJJ-IHRRRGAJSA-N 0.000 description 1
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 1
- SSWJYJHXQOYTSP-SRVKXCTJSA-N Pro-His-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(O)=O SSWJYJHXQOYTSP-SRVKXCTJSA-N 0.000 description 1
- LPGSNRSLPHRNBW-AVGNSLFASA-N Pro-His-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C([O-])=O)NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 LPGSNRSLPHRNBW-AVGNSLFASA-N 0.000 description 1
- VZKBJNBZMZHKRC-XUXIUFHCSA-N Pro-Ile-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O VZKBJNBZMZHKRC-XUXIUFHCSA-N 0.000 description 1
- YXHYJEPDKSYPSQ-AVGNSLFASA-N Pro-Leu-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 YXHYJEPDKSYPSQ-AVGNSLFASA-N 0.000 description 1
- FXGIMYRVJJEIIM-UWVGGRQHSA-N Pro-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FXGIMYRVJJEIIM-UWVGGRQHSA-N 0.000 description 1
- FKYKZHOKDOPHSA-DCAQKATOSA-N Pro-Leu-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FKYKZHOKDOPHSA-DCAQKATOSA-N 0.000 description 1
- KDBHVPXBQADZKY-GUBZILKMSA-N Pro-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KDBHVPXBQADZKY-GUBZILKMSA-N 0.000 description 1
- FDMKYQQYJKYCLV-GUBZILKMSA-N Pro-Pro-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 FDMKYQQYJKYCLV-GUBZILKMSA-N 0.000 description 1
- CNILNQMBAHKMFS-UHFFFAOYSA-M Pyrithiobac-sodium Chemical compound [Na+].COC1=CC(OC)=NC(SC=2C(=C(Cl)C=CC=2)C([O-])=O)=N1 CNILNQMBAHKMFS-UHFFFAOYSA-M 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- BTKUIVBNGBFTTP-WHFBIAKZSA-N Ser-Ala-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(O)=O BTKUIVBNGBFTTP-WHFBIAKZSA-N 0.000 description 1
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 1
- NLQUOHDCLSFABG-GUBZILKMSA-N Ser-Arg-Arg Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NLQUOHDCLSFABG-GUBZILKMSA-N 0.000 description 1
- MESDJCNHLZBMEP-ZLUOBGJFSA-N Ser-Asp-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MESDJCNHLZBMEP-ZLUOBGJFSA-N 0.000 description 1
- SWSRFJZZMNLMLY-ZKWXMUAHSA-N Ser-Asp-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O SWSRFJZZMNLMLY-ZKWXMUAHSA-N 0.000 description 1
- AEGUWTFAQQWVLC-BQBZGAKWSA-N Ser-Gly-Arg Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O AEGUWTFAQQWVLC-BQBZGAKWSA-N 0.000 description 1
- KDGARKCAKHBEDB-NKWVEPMBSA-N Ser-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CO)N)C(=O)O KDGARKCAKHBEDB-NKWVEPMBSA-N 0.000 description 1
- AMRRYKHCILPAKD-FXQIFTODSA-N Ser-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CO)N AMRRYKHCILPAKD-FXQIFTODSA-N 0.000 description 1
- NIOYDASGXWLHEZ-CIUDSAMLSA-N Ser-Met-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O NIOYDASGXWLHEZ-CIUDSAMLSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- ZUXQFMVPAYGPFJ-JXUBOQSCSA-N Thr-Ala-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN ZUXQFMVPAYGPFJ-JXUBOQSCSA-N 0.000 description 1
- CEXFELBFVHLYDZ-XGEHTFHBSA-N Thr-Arg-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O CEXFELBFVHLYDZ-XGEHTFHBSA-N 0.000 description 1
- LMMDEZPNUTZJAY-GCJQMDKQSA-N Thr-Asp-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O LMMDEZPNUTZJAY-GCJQMDKQSA-N 0.000 description 1
- LHEZGZQRLDBSRR-WDCWCFNPSA-N Thr-Glu-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LHEZGZQRLDBSRR-WDCWCFNPSA-N 0.000 description 1
- KCRQEJSKXAIULJ-FJXKBIBVSA-N Thr-Gly-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O KCRQEJSKXAIULJ-FJXKBIBVSA-N 0.000 description 1
- IMULJHHGAUZZFE-MBLNEYKQSA-N Thr-Gly-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IMULJHHGAUZZFE-MBLNEYKQSA-N 0.000 description 1
- MPUMPERGHHJGRP-WEDXCCLWSA-N Thr-Gly-Lys Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N)O MPUMPERGHHJGRP-WEDXCCLWSA-N 0.000 description 1
- XOWKUMFHEZLKLT-CIQUZCHMSA-N Thr-Ile-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O XOWKUMFHEZLKLT-CIQUZCHMSA-N 0.000 description 1
- FIFDDJFLNVAVMS-RHYQMDGZSA-N Thr-Leu-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O FIFDDJFLNVAVMS-RHYQMDGZSA-N 0.000 description 1
- JLNMFGCJODTXDH-WEDXCCLWSA-N Thr-Lys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O JLNMFGCJODTXDH-WEDXCCLWSA-N 0.000 description 1
- VTMGKRABARCZAX-OSUNSFLBSA-N Thr-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O VTMGKRABARCZAX-OSUNSFLBSA-N 0.000 description 1
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 1
- CSNBWOJOEOPYIJ-UVOCVTCTSA-N Thr-Thr-Lys Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O CSNBWOJOEOPYIJ-UVOCVTCTSA-N 0.000 description 1
- CJEHCEOXPLASCK-MEYUZBJRSA-N Thr-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@H](O)C)CC1=CC=C(O)C=C1 CJEHCEOXPLASCK-MEYUZBJRSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- BRBCKMMXKONBAA-KWBADKCTSA-N Trp-Ala-Ala Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 BRBCKMMXKONBAA-KWBADKCTSA-N 0.000 description 1
- NKUIXQOJUAEIET-AQZXSJQPSA-N Trp-Asp-Thr Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@H](O)C)C(O)=O)=CNC2=C1 NKUIXQOJUAEIET-AQZXSJQPSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- JONPRIHUYSPIMA-UWJYBYFXSA-N Tyr-Ala-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JONPRIHUYSPIMA-UWJYBYFXSA-N 0.000 description 1
- DXYWRYQRKPIGGU-BPNCWPANSA-N Tyr-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 DXYWRYQRKPIGGU-BPNCWPANSA-N 0.000 description 1
- USYGMBIIUDLYHJ-GVARAGBVSA-N Tyr-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 USYGMBIIUDLYHJ-GVARAGBVSA-N 0.000 description 1
- DWAMXBFJNZIHMC-KBPBESRZSA-N Tyr-Leu-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O DWAMXBFJNZIHMC-KBPBESRZSA-N 0.000 description 1
- SINRIKQYQJRGDQ-MEYUZBJRSA-N Tyr-Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SINRIKQYQJRGDQ-MEYUZBJRSA-N 0.000 description 1
- NWEGIYMHTZXVBP-JSGCOSHPSA-N Tyr-Val-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O NWEGIYMHTZXVBP-JSGCOSHPSA-N 0.000 description 1
- SLLKXDSRVAOREO-KZVJFYERSA-N Val-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N)O SLLKXDSRVAOREO-KZVJFYERSA-N 0.000 description 1
- ROLGIBMFNMZANA-GVXVVHGQSA-N Val-Glu-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N ROLGIBMFNMZANA-GVXVVHGQSA-N 0.000 description 1
- UEHRGZCNLSWGHK-DLOVCJGASA-N Val-Glu-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UEHRGZCNLSWGHK-DLOVCJGASA-N 0.000 description 1
- APQIVBCUIUDSMB-OSUNSFLBSA-N Val-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N APQIVBCUIUDSMB-OSUNSFLBSA-N 0.000 description 1
- OTJMMKPMLUNTQT-AVGNSLFASA-N Val-Leu-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](C(C)C)N OTJMMKPMLUNTQT-AVGNSLFASA-N 0.000 description 1
- VPGCVZRRBYOGCD-AVGNSLFASA-N Val-Lys-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O VPGCVZRRBYOGCD-AVGNSLFASA-N 0.000 description 1
- WANVRBAZGSICCP-SRVKXCTJSA-N Val-Pro-Met Chemical compound CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)C(O)=O WANVRBAZGSICCP-SRVKXCTJSA-N 0.000 description 1
- GVNLOVJNNDZUHS-RHYQMDGZSA-N Val-Thr-Lys Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O GVNLOVJNNDZUHS-RHYQMDGZSA-N 0.000 description 1
- ZLNYBMWGPOKSLW-LSJOCFKGSA-N Val-Val-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLNYBMWGPOKSLW-LSJOCFKGSA-N 0.000 description 1
- VVIZITNVZUAEMI-DLOVCJGASA-N Val-Val-Gln Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCC(N)=O VVIZITNVZUAEMI-DLOVCJGASA-N 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000004458 antinutrient Nutrition 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010036533 arginylvaline Proteins 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- XMQFTWRPUQYINF-UHFFFAOYSA-N bensulfuron-methyl Chemical group COC(=O)C1=CC=CC=C1CS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 XMQFTWRPUQYINF-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 108010054812 diprotin A Proteins 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010075431 glycyl-alanyl-phenylalanine Proteins 0.000 description 1
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 108010031424 isoleucyl-prolyl-proline Proteins 0.000 description 1
- 108010077158 leucinyl-arginyl-tryptophan Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 108010012058 leucyltyrosine Proteins 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 108010018625 phenylalanylarginine Proteins 0.000 description 1
- 108010025488 pinealon Proteins 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108010025826 prolyl-leucyl-arginine Proteins 0.000 description 1
- 108700042769 prolyl-leucyl-glycine Proteins 0.000 description 1
- 108010093296 prolyl-prolyl-alanine Proteins 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 108010004914 prolylarginine Proteins 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- FUXJMHXHGDAHPD-UHFFFAOYSA-N pyrimidine-2-carboxamide Chemical class NC(=O)C1=NC=CC=N1 FUXJMHXHGDAHPD-UHFFFAOYSA-N 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000012250 transgenic expression Methods 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
- 108010009962 valyltyrosine Proteins 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1022—Transferases (2.) transferring aldehyde or ketonic groups (2.2)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
- A01H4/001—Culture apparatus for tissue culture
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
- A01H4/008—Methods for regeneration to complete plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
- C12N15/821—Non-antibiotic resistance markers, e.g. morphogenetic, metabolic markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
- C12N15/8278—Sulfonylurea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y202/00—Transferases transferring aldehyde or ketonic groups (2.2)
- C12Y202/01—Transketolases and transaldolases (2.2.1)
- C12Y202/01006—Acetolactate synthase (2.2.1.6)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Botany (AREA)
- Environmental Sciences (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to the technical field of agricultural biology, in particular to a rice A L S mutant gene, a plant transgenic screening vector pCA L Sm2 containing the gene and application thereof, wherein the amino acid sequence of the rice A L S mutant protein is shown as SEQ ID NO.1, the plant genetic transformation screening vector disclosed by the invention utilizes an expression cassette of the rice A L S mutant gene as a screening marker, herbicides such as pyrimidine salicylic acid and imidazolinone are used as screening agents in a callus screening stage, and the obtained transgenic plant has high resistance of the herbicides such as the pyrimidine salicylic acid and the imidazolinone.
Description
Technical Field
The invention relates to the technical field of agricultural biology, in particular to a rice A L S mutant gene, a plant transgenic screening expression cassette containing the gene, a plant transgenic screening vector containing the expression cassette and application thereof.
Background
With the rapid development of genetic engineering and molecular biology techniques, the application range of transgenic technology is more and more extensive. The transgenic technology has a plurality of advantages, such as widening available gene resources and creating new germplasm resources; can carry out directional and fixed-point variation and selection on plant physical traits; provides a new way for cultivating high-yield, high-quality and high-resistance fine varieties and the like. Transgenic crops are approved to be commercially planted in 1996, and 23 transgenic crops are totally approved for commercial production in 2017 worldwide, and the transgenic crops relate to more than 16 types of target traits including insect resistance, herbicide resistance, disease resistance, fertility change, quality improvement and the like. According to statistics, transgenic crops such as soybeans, corns, cottons, rapes and the like mainly resisting herbicides and insects are planted in 26 countries and regions in the world in 2017, and the area reaches 1.9 hundred million hectares. The large-area popularization of the transgenic crops makes great contribution to the global agricultural production.
At present, with the continuous popularization of transgenic products, people tend to be objective and positive in attitude of the transgenic products, but the controversial effects on the transgenic products are still serious, and the potential safety risk problems of the transgenic products are still generally concerned, so that the transgenic products need to be strictly controlled and supervised. One of the key issues for transgenic crops is the potential risk that a selectable marker may pose, and its resistance to target organisms, allergenicity of the expressed protein, and its effects on the nutrients, natural toxins and anti-nutrient content of the recipient crop itself are unknown after transfer into the plant. The most used at present are antibiotic and herbicide screening markers, such as hygromycin-HPT screening system, kanamycin-NPTII screening system, glufosinate-Bar screening system, etc. Most of these selection markers are foreign genes derived from bacteria, etc., which is also one of the causes of public concern. The risks and concerns posed by foreign genes can be eliminated if plants can be re-transformed with genes endogenous to the plant as selectable markers.
Acetolactate synthase (acetolactate synthase, A L S; EC2.2.1.6) is a key enzyme catalyzing the initiation of the synthesis of branched-chain amino acids (isoleucine, leucine and valine) in plants (Herrera-Estra L D, M essens E, et al, chiral genes AS major selectable markers in plants, 1983,2(6): 987-19-995.), is absent in animals, so that the biosynthesis of branched-chain amino acids can be blocked by inhibition of the A L S enzyme for the purpose of eliminating plant weeds, and is harmless to humans and animals.A mutation at a certain site in the amino acid sequence of A L S has been developed and applied against this enzyme, for example sulfonylureas, imidazolinones, pyrimidinamides and sulfonamides, etc., makes the A L S protein structure altered, resulting in binding of inhibitors of A L S, A6723S, A L, which makes it impossible to produce resistance to microorganisms (hormone, S23, scientific, S23, 11. 12. this patent publication No. 7-S. 11. the invention also discloses that the enzyme can reduce the sensitivity of microorganisms to plants (hormone, S23, Escherichia coli, S23, Escherichia coli, S23, Escherichia coli, III) and S23. 9. A3. supplement, III. 7. 9. A3. A.
Disclosure of Invention
The invention aims to provide a rice A L S mutant protein and a coding gene thereof, and provides a vector for applying a plant genetic transformation screening by using a plant endogenous gene as a screening marker to solve the problem of potential safety risk caused by using an exogenous screening marker in the current genetic transformation.
In order to achieve the purpose, the technical scheme of the invention is as follows:
according to the first aspect, the invention provides rice A L S mutant protein, wherein the A L S mutant protein has amino acid mutations at positions 95, 548 and 627 compared with wild type A L S protein.
In the A L S mutant protein, the amino acid mutations at positions 95, 548 and 627 can be the mutation of the amino acids at positions 95, 548 and 627 of the wild-type A L S protein of the plant into any one of alanine, serine, phenylalanine, tyrosine, valine, cysteine, glycine, histidine, arginine, lysine, isoleucine, leucine, tryptophan, methionine, asparagine, glutamine, aspartic acid, glutamic acid and threonine.
Preferably, the a L S mutein is mutated from Gly to Ala at position 95, Trp to L eu at position 548 and Ser to Ile at position 627 relative to the wild-type a L S protein.
More preferably, the a L S mutein has the amino acid sequence of (1) or (2) below:
(1) an amino acid sequence shown as SEQ ID NO. 1;
(2) the amino acid sequence of the A L S mutant protein which is obtained by substituting, inserting or deleting one or more amino acids in the amino acid sequence shown as SEQ ID NO.1 and can enable plants to have the resistance of A L S inhibitor herbicides.
The rice A L S mutant protein provided by the invention has higher resistance to imidazolinone, pyrimidine salicylic acid, sulfonylurea or sulfonamide herbicides.
The invention provides a nucleic acid for coding the A L S mutant protein, and all nucleic acid sequences capable of coding the A L S mutant protein are in the protection scope of the invention, such as a nucleotide sequence shown as SEQ ID NO. 2.
The present invention provides biological material comprising a nucleic acid encoding the a L S mutein, in particular an expression cassette, a vector, a host cell or a transgenic plant cell line comprising a nucleic acid encoding the a L S mutein.
The invention provides any one of the following applications of the A L S mutant protein or the nucleic acid encoding the A L S mutant protein or the biological material containing the nucleic acid:
(1) use in conferring resistance to an a L S inhibitor herbicide or increasing resistance to an a L S inhibitor herbicide in a plant;
(2) the application in preparing transgenic plants;
(3) the application in the improvement of plant germplasm resources;
(4) the application of the gene expression vector in the selection of plant genetic transformation or the construction of plant genetic transformation selection vectors.
The A L S inhibitor herbicide provided by the invention comprises, but is not limited to, imidazolinone, pyrimidine salicylic acid, sulfonylurea or sulfonamide herbicides.
Plants of the invention include, but are not limited to, rice, maize, wheat, soybean, sorghum, peanut, sesame, cotton, linseed, grain, oat, rapeseed, barley, rye, millet, tobacco, highland barley, arabidopsis, and the like. Preferably, the plant is rice, maize, wheat, soybean, sorghum, peanut or millet.
In a second aspect, the present invention provides a plant transgene screening expression cassette having a plant endogenous gene as a screening marker, the plant endogenous gene being an a L S mutant gene.
Preferably, the A L S mutant gene is a rice A L S mutant gene.
More preferably, the protein encoded by the rice A L S mutant gene (A L Sm2) is the A L S mutant protein disclosed by the invention.
The invention finds that the A L S mutant protein with the sequence shown in SEQ ID NO.1 is more suitable to be used as a screening marker, and can more efficiently play the function of the screening marker in the process of plant gene transformation.
The nucleotide sequence of the rice A L S mutant gene (A L Sm2) can be the nucleotide sequence shown in SEQ ID NO. 2.
The plant transgene screening expression cassette further comprises a promoter and a terminator for initiating and terminating transcription of the a L S mutant gene.
The promoter may be a plant constitutive promoter or a plant tissue specific promoter.
The plant constitutive promoter can be a rice A L S gene promoter, a Ubi promoter or an Actin promoter of rice or corn, and the plant tissue specific promoter can be a Rubisco small subunit promoter or a Cab promoter.
Preferably, the promoter is a rice A L S gene promoter.
The terminator may be a DNA sequence capable of terminating gene transcription in plants, including a rice A L S gene terminator, a Ubi terminator, and the like.
Preferably, the terminator is a rice Ubi terminator.
The invention discovers that the transcription of the rice A L S mutant gene can be better controlled by adopting the rice A L S gene promoter and the Ubi terminator to cooperate and regulate, so that the high-efficiency, stable and appropriate expression of the A L S mutant gene can be better controlled, and the A L S gene mutant can better exert the function of screening and marking.
As a preferred scheme of the invention, the nucleotide sequence of the plant transgenic screening expression cassette is shown as SEQ ID No. 3.
The invention provides application of the A L S mutant gene as a screening marker for plant genetic transformation.
Based on the plant transgenic screening expression cassette, the invention further provides a plant genetic transformation screening vector, which contains the plant transgenic screening expression cassette.
Preferably, the plant genetic transformation screening vector is a plant binary expression vector, and can be used for genetic transformation by cloning other expression cassettes into the vector; the other expression cassettes refer to expression cassettes other than the plant transgene screening expression cassette, and include but are not limited to fluorescent protein expression cassettes, GUS reporter gene expression cassettes, insect-resistant expression cassettes, herbicide-resistant expression cassettes and the like.
More preferably, the plant genetic transformation screening vector of the present invention further comprises a series of multiple cloning sites such as AfeI, AvrII, PmlI, SnaBI, AloI, PmeI, etc. to allow for the subsequent cloning of the gene of interest.
As a preferred scheme of the invention, the plant genetic transformation screening vector provided by the invention is pCA L Sm2, and the nucleotide sequence of the vector is shown as SEQ ID NO. 4.
The plant genetic transformation screening vector can be prepared by the following method:
(1) constructing a plant transgenic screening expression cassette, namely placing an A L S mutant gene with a sequence shown as SEQ ID NO.2 under the drive of a promoter A L Spro of the gene to express, and terminating expression by a rice Ubi terminator at the downstream of the mutant gene to obtain the plant transgenic screening expression cassette with the sequence shown as SEQ ID NO. 3;
(2) the plant transgenic screening expression cassette is connected with a plant binary expression vector pC0310 to obtain the plant genetic transformation screening vector.
The invention also provides application of the A L S mutant protein or the plant transgenic screening expression cassette in serving as a plant genetic transformation screening marker.
The invention also provides application of the A L S mutant protein or the plant transgenic screening expression cassette or the plant genetic transformation screening vector in plant genetic transformation.
The application specifically comprises the following steps: after the plant transgenic screening expression cassette or the plant genetic transformation screening carrier is transferred into the plant callus, the callus is inoculated into a screening culture medium added with herbicide in the screening stage for resistance screening.
The herbicide may be a pyrimidinylsalicylate or imidazolinone herbicide, for example: bispyribac-sodium, imazapyr or imazethapyr.
Preferably, the screening culture medium contains 0.25-1 mu mol/L Bispyribac-sodium, 200-1000 mu g/L Mexican-P or 300-1000 mu g/L imazethapyr.
In the screening medium, the screening efficiency is preferably good when the screening medium contains 0.3-0.4 mu mol/L bispyribac-sodium, more preferably 0.4 mu mol/L bispyribac-sodium, or the screening efficiency is good when the screening medium contains 200-20 mu g/L imazapyr, more preferably 250-300 mu g/L imazapyr, or the screening efficiency is good when the screening medium contains 300-500 mu g/L imazethapyr, more preferably 400-500 mu g/L imazethapyr.
Further, the application specifically comprises: and in the differentiation stage after the plant transgenic screening expression cassette or the plant genetic transformation screening vector is transferred into the plant callus, performing differentiation culture on the positive callus obtained from the screening culture medium by adopting a differentiation culture medium containing herbicide.
The herbicide may be a pyrimidinylsalicylate or imidazolinone herbicide, for example: bispyribac-sodium, imazapyr or imazethapyr.
Preferably, the differentiation medium contains 0.05-1 mu mol/L Bispyribac-sodium, 25-1000 mu g/L Mexican-P or 25-1000 mu g/L imazethapyr.
The differentiation medium preferably contains 0.05-0.25 mu mol/L bispyribac-sodium, more preferably contains 0.1 mu mol/L bispyribac-sodium to obtain good differentiation efficiency, or preferably contains 30-100 mu g/L imazapyr, more preferably contains 50 mu g/L imazapyr to obtain good differentiation efficiency, or preferably contains 30-100 mu g/L imazethapyr, more preferably contains 50 mu g/L imazethapyr to obtain good differentiation efficiency, and simultaneously effectively inhibits the non-transgenic callus from differentiating into seedlings.
Further, the application specifically comprises: and in the rooting stage after the plant transgenic screening expression box or the plant genetic transformation screening vector is transferred into the plant callus, carrying out rooting culture on the positive seedling obtained by differentiation culture by adopting a rooting culture medium containing herbicide.
The herbicide may be a pyrimidinylsalicylate or imidazolinone herbicide, for example: bispyribac-sodium, imazapyr or imazethapyr.
Preferably, the rooting medium contains 0.05-10 mu mol/L Bispyribac-sodium, 25-1000 mu g/L Mexican-P or 25-1000 mu g/L imazethapyr.
The rooting medium preferably contains 0.05-5 mu mol/L bispyribac-sodium, more preferably contains 0.1 mu mol/L bispyribac-sodium to obtain good rooting efficiency, or preferably contains 50-100 mu g/L imazapyr, more preferably contains 50 mu g/L imazapyr to obtain good rooting efficiency, or preferably contains 50-100 mu g/L imazethapyr, more preferably contains 50 mu g/L imazethapyr to obtain good rooting efficiency, and simultaneously effectively inhibits the rooting of the non-transgenic differentiated seedlings.
Taking rice as an example, other plant transgenic methods can refer to rice:
1) induction: after rice seeds are shelled and disinfected, mature embryos are inoculated in an induction culture medium to induce embryonic callus, and dark culture is carried out for 30-50 days at the temperature of 27 ℃;
2) infection: separating the callus obtained in the step 1) from endosperm and buds, inoculating the callus into a suspension of agrobacterium carrying the plant genetic transformation screening vector (suspending the agrobacterium carrying the plant genetic transformation screening vector in a suspension culture medium) for infection, standing for 30 minutes at room temperature, and then airing for later use;
3) co-culturing: transferring the dried callus into a co-culture medium, and performing dark culture at 22 ℃ for 3 days until thalli appear on the surface of the callus;
4) screening: cleaning the co-cultured callus, inoculating to a screening culture medium containing bispyribac-sodium, imazapyr or imazethapyr, performing dark culture at 27 deg.C for 30-50 days, and screening for resistance;
5) differentiation: inoculating the obtained resistant callus onto a differentiation culture medium added with bispyribac-sodium, imazapyr or imazethapyr, and performing illumination culture at 27 ℃ for 25-40 days until seedlings are differentiated;
6) rooting: inoculating the seedling to a rooting culture medium added with bispyribac-sodium, imazapyr or imazethapyr for rooting, performing illumination culture at 30 ℃ for 10-20 days, performing PCR detection, and selecting the plant which is detected to be positive for planting;
the specific formula of the culture medium is as follows:
the induction medium is N6D medium, which is a medium taking N6 medium as a basic medium, and contains 3 mg/L of 2, 4-dichlorophenoxyacetic acid (2,4-D), 0.3-0.6 g/L of hydrolyzed Casein (CH), 0.3-0.5 g/L of proline (Pro), 30 g/L of sucrose, 3 g/L of plant gel (Phytagel) and 5.9 of pH value;
the suspension culture medium is N6-AA culture medium, which takes N6 culture medium AS basic culture medium, and contains 2, 4-dichlorophenoxyacetic acid (2,4-D) with the concentration of 2 mg/L, hydrolyzed Casein (CH) with the concentration of 0.3-0.6 g/L, proline (Pro) with the concentration of 0.3-0.5 g/L, sucrose with the concentration of 20 g/L, glucose with the concentration of 10 g/L, Acetosyringone (AS) with the concentration of 100-;
the co-culture medium is N6-AS culture medium, which takes N6 culture medium AS basic culture medium, and contains 2, 4-dichlorophenoxyacetic acid (2,4-D) with the concentration of 2 mg/L, hydrolyzed Casein (CH) with the concentration of 0.3-0.6 g/L, proline (Pro) with the concentration of 0.3-0.5 g/L, sucrose with the concentration of 20 g/L, glucose with the concentration of 10 g/L, Acetosyringone (AS) with the concentration of 100-;
the screening culture medium is N6S culture medium, which is culture medium taking N6 culture medium as basic culture medium, and contains 2, 4-dichlorophenoxyacetic acid (2,4-D) with concentration of 2-3 mg/L, hydrolyzed Casein (CH) with concentration of 0.6-1 g/L, proline (Pro) with concentration of 0.5-1.5 g/L, sucrose with concentration of 30 g/L, plant gel (Phytagel) with concentration of 3 g/L, and cephalosporin (Cn) with concentration of 500 mg/L, bispyribac sodium with concentration of 0.25-1 μmol/L, or imazapyr with concentration of 200 μ g/L, or imazethapyr with concentration of 300 μ g/L, and pH value of 5.8;
the differentiation medium is MSRe medium, which takes MS medium as basic medium, and contains 1-2 mg/L concentration of Kinetin (KT), 0.5-2 mg/L concentration of α -naphthylacetic acid (NAA), 20-40 g/L concentration of sorbitol, 30 g/L concentration of sucrose and 3 g/L concentration of plant gel (Phytagel), wherein the concentration of bispyribac-sodium serving as screening agent in the differentiation medium is 0.05-1 mu mol/L, or the concentration of imazapyr is 25-1000 mu g/L, or the concentration of imazethapyr is 25-1000 mu g/L, and the pH value is 5.9;
the rooting culture medium is 1/2MSR culture medium, which is culture medium using 1/2MS culture medium as basic culture medium, containing 20 g/L of sucrose, 0.5-1 mg/L of paclobutrazol and 3 g/L of plant gel (Phytagel), wherein the concentration of bispyribac-sodium as screening agent in the rooting culture medium is 0.05-10 mu mol/L, the concentration of imazapyr is 25-1000 mu g/L or the concentration of imazethapyr is 25-1000 mu g/L, and the pH value is 5.8;
the invention has the beneficial effects that the invention provides rice A L S mutant protein which can lead the plant to be highly resistant to A L S inhibitor herbicides, and also provides a plant transgenic screening expression box using the rice A L S mutant gene as a screening marker, a plant genetic transformation screening carrier and a corresponding gene transformation screening method.
Drawings
FIG. 1 is an electrophoretogram of pCA L Sm2 vector digested by XhoI in example 1 of the present invention, wherein M is Marker, CK is an undigested pCA L Sm2 recombinant plasmid, and 1-8 are digested pCA L Sm2 recombinant plasmid, which can cut out a fragment of about 1.7kb in size.
FIG. 2 shows the results of PCR detection of Agrobacterium after transformation in example 2, wherein M is Marker, 1 is negative control (water as template), 2 is pCA L Sm2 recombinant plasmid positive control, and 3-11 is pCA L Sm2 recombinant plasmid Agrobacterium monoclonal antibody sample (5 is negative).
FIG. 3 is a map of the pC0310 vector in example 1 of the present invention.
FIG. 4 is a map of pCA L Sm2 vector in example 1 of the present invention.
FIG. 5 is a comparison chart of critical concentration test of bispyribac-sodium in seedling stage of common rice in example 3, wherein the left side of the seedling pot is 9311, the right side is ZH11, wherein 0 represents no bispyribac-sodium, 10 × represents 300 mg/L, and 20 × represents 600 mg/L.
FIG. 6 is a test chart of critical concentration of imazapyr in seedling stage of ordinary rice in example 3, wherein 0.2 × represents 19.6 mg/L, 0.5 ×,1 ×,2 × and 5 × are corresponding multiples respectively, and seedlings in seedling pots are ZH 11.
FIG. 7 shows critical concentration tests of imazethapyr in seedling stage of ordinary rice in example 3 of the present invention, wherein 5 × represents 375 mg/L, 20 ×, 50 ×, 100 × and 300 × are corresponding multiples respectively, and seedlings in seedling pots are ZH 11.
FIG. 8 shows the results of critical concentration test of rice calli on bispyribac-sodium resistance in example 4 of the present invention, wherein N6 is the result of screening calli on culture without screening pressure for 40 days, and N6+ is the screening pressure of bispyribac-sodium added for 0.25, 0.5, 1 and 2. mu. mol/L, respectively.
FIG. 9 shows the results of callus screening with bispyribac-sodium screening medium in example 8 of the present invention for 40 days.
FIG. 10 shows the results of differentiation of callus 30d by adding bispyribac-sodium, imazapyr or imazethapyr to the differentiation medium in examples 14, 20 and 28 of the present invention, wherein 1 and 2 are differentiation cultures with bispyribac (0.1. mu. mol/L), 3 and 4 are differentiation cultures with imazapyr (50. mu.g/L), and 5 and 6 are differentiation cultures with imazethapyr (50. mu.g/L), wherein 1, 3 and 5 are non-transgenic calli and 2,4 and 6 are transgenic positive calli.
FIG. 11 shows the results of rooting 15 days after adding bispyribac-sodium, imazapyr or imazethapyr to the rooting medium in examples 37, 47 and 55 of the present invention, wherein 1 and 2 are rooting culture with bispyribac (0.1. mu. mol/L), 3 and 4 are rooting culture with imazapyr (50. mu.g/L), and 5 and 6 are rooting culture with imazethapyr (50. mu.g/L), wherein 1, 3 and 5 are rooting for non-transgenic differentiated seedlings, and 2,4 and 6 are rooting for transgenic positive differentiated seedlings.
FIG. 12 is a PCR detection electrophoretogram of transgenic sample plants in example 63 of the present invention; wherein M is Marker, 1 is H2O and 2 are genome DNA of a ZH11 non-transgenic plant, 3 is a plasmid positive control, and 4-24 are genome DNA of a transgenic plant obtained by screening.
FIG. 13 shows the results of the herbicide resistance test of T0 transgenic line in example 64 of the present invention; wherein, a-d: spraying 90mg/m after the bispyribac-sodium screening plant line is transplanted2And a-d are respectively before spraying, 7 days, 14 days and 21 days after spraying, arrows in the figure show that wild type contrast ZH11 completely dies after 14 days of spraying, e and f are respectively to spray 2 × (196 mg/L) imazapyr after the imazapyr screening strain is transplanted, e is to spray 20 × (1500 mg/L) imazethapyr after 21 days of spraying, g-h is to spray imazethapyr screening strain, g is to spray 25 (1500 mg/L) imazethapyr before and h is to spray 21 days, wherein ZH11 is wild type contrast, and 25, 25-1, 38-1, 41-1 and 50-1 are all transgenic strains.
Detailed Description
Preferred embodiments of the present invention will be described in detail with reference to the following examples. It is to be understood that the following examples are given for illustrative purposes only and are not intended to limit the scope of the present invention. Various modifications and alterations of this invention will become apparent to those skilled in the art without departing from the spirit and scope of this invention.
The experimental procedures used in the following examples are all conventional procedures unless otherwise specified.
Materials, reagents and the like used in the following examples are commercially available unless otherwise specified.
Example 1 construction of a vector for genetic transformation screening of plants containing the Rice A L S mutein
1. Obtaining of Rice A L S mutant protein
The invention carries out a large amount of analysis and combination comparison on the existing herbicide resistance mutant sites of a plant A L S, and obtains an A L S mutant protein (the amino acid sequence is shown as SEQ ID NO.1, and the nucleotide sequence of the coding gene is shown as SEQ ID NO. 2) with amino acid mutation at the 95 th position (Gly is mutated into Ala), the 548 th position (Trp is mutated into L eu) and the 627 th position (Ser is mutated into Ile) relative to the rice wild type A L S protein from different site combinations, wherein the mutant protein has higher A L S inhibitor resistance compared with each single-point mutant at the 95 th position, the 548 th position and the 627 th position and other site combination mutants, solves the problem that each mutant has single-point resistance to herbicides, has higher resistance to imidazolinones, pyrimidine salicylic acids, sulfonylureas or sulfonamide herbicides, can endow the plant with high resistance to a plurality of A L S inhibitor herbicides, and can provide an effective solution for the rotation of a plurality of herbicides.
2. Preparation of plant transgene screening expression cassette
The construction method of the plant transgenic screening expression cassette OsA L SP-A L Sm2-OsUbiT (the sequence is shown as SEQ ID NO. 3) of the invention is as follows:
designing primers 0310-AA2U-F/0310-AA2U-Rv1 to amplify a promoter OsA L SP fragment from a rice genome, amplifying a target gene A L Sm2 fragment from a synthetic rice A L S mutant gene (A L Sm2) fragment by using primers 0310-AA2U-F2/0310-AA2U-Rv2, amplifying a terminator OsUbiT fragment from the rice genome by using primers 0310-AA2 469-F6862/0310-AA 2U-Rv, wherein about 15 nucleotide sequences are repeated at the corresponding connecting positions of the 5 'ends of the primers 0310-AA2U-F and 0310-AA2U-Rv, 15bp repeats are also arranged at the 5' ends of the upper and lower primers of adjacent fragments (0310-AA2U-Rv1, 0310-AA2 AA U-F2, 0310-AA2 Rv 03172) and recombining the gene AsUbiT fragment with Asubb 2 and then using primers 0310-AA 2-03172 to obtain a recombinant gene Asubb 2.
The primer sequences are as follows:
0310-AA2U-F:CGTTTTTAATGTATGCTCCACCATGttggCGTAAAGTCTTCACTCCTCCCCC(SEQID NO.5);
0310-AA2U-Rv1:CGTAGCCATGGTGGGTGGTGGCGG(SEQ ID NO.6);
0310-AA2U-F2:CACCCACCATGGCTACGACCGCCGC(SEQ ID NO.7);
0310-AA2U-Rv2:GGCTGAGGACTCTAGATTAATACACAGTCCTGCCATCA(SEQ ID NO.8);
0310-AA2U-F3:TGTATTAATCTAGAGTCCTCAGCCATAGAGCTG(SEQ ID NO.9);
0310-AA2U-Rv:TGCCCGGGCCTGCAgGACAAATTTGTTTGTCAGATCAAATTTTTAAGC(SEQ IDNO.10)。
the PCR amplification reaction system is as follows:
the PCR amplification procedure was as follows: pre-denaturation at 94 ℃ for 3 min; denaturation at 94 ℃ for 30s, annealing at 55-65 ℃ for 30s, extension at 68 ℃ for 3min, and 35 cycles; extension was carried out at 68 ℃ for 10min and at 16 ℃ was stopped.
PCR products amplified by primers 0310-AA2U-F and 0310-AA2U-Rv1 are OsA L SP fragments, the size of the products is 2180bp which is recovered by 1% agarose gel electrophoresis, PCR products amplified by primers 0310-AA2U-F2 and 0310-AA2U-Rv2 are A L Sm2 fragments, the size of the products amplified by 1% agarose gel electrophoresis is 1941bp, PCR products amplified by primers 0310-AA2U-F3 and 0310-AA2U-Rv are OsUbiT fragments, and the size of the products amplified by 1% agarose gel electrophoresis is 310 bp.
3. Construction of plant genetic transformation screening vector
The amplification product in 1 is inserted into a pC0310 vector (pC0310 is a pC AMBIA1300 vector skeleton supported by the inventor and is obtained by modification, wherein the pC0310 mainly deletes a hygromycin screening element and an unnecessary region of an adjacent region so that the interior of the T-Border does not contain other bacterial sequences except a multiple cloning site, therefore, a plant-derived sequence is subsequently connected into the T-Border, the public transgenic concern is reduced when the T-Border is transferred into a plant, and a vector map is shown in figure 3) between BstXI and PstI double enzyme cutting sites, wherein the method comprises the following steps:
(1) vector plasmid pC0310 was double digested with BstXI + PstI, electrophoresed through an agarose gel using E.Z.N.A.The Extraction kit (Omega, the same below) recovered a band of about 7kb in size, giving a pC0310 linear fragment.
The BstXI + PstI double-enzyme digestion reaction system is as follows:
(2)2 ×L lightening Cloning Kit connection KitOsA L SP-A L Sm2-OsUbiT expression cassette is connected to pC0310 vector, and the connection system is as follows:
and (3) connecting procedures: 50 ℃ for 30 min.
(3) And (2) transforming, namely adding 2 mu l of the ligation product into an escherichia coli competent cell, slightly mixing the ligation product uniformly, carrying out ice bath for half an hour, transforming the escherichia coli competent cell by using an electrotransfer instrument with 1.8KV electric shock, adding 1ml of L B culture medium, carrying out shaking culture at 37 ℃ and 220rpm for 1h, centrifuging at 5000rpm for 30s, discarding 800 mu l of supernatant, uniformly mixing the residual thallus with the culture medium, coating the mixture on a L B plate containing kanamycin, carrying out culture at 37 ℃ for about 16h, picking out single colonies, carrying out colony PCR (polymerase chain reaction) verification by using specific primers (0310-F2 and 0310-R2), picking out positive colonies, shaking the colonies overnight at 37 ℃ and 220rpm, extracting plasmids by using a high-purity plasmid miniextraction kit (Zhongkeitai), carrying out enzyme digestion detection correct (as shown in figure 1), carrying out sequencing and sending a sequence to be named pCA L Sm2, wherein a vector map is shown in figure 4, and the nucleotide sequence.
The primer sequence is as follows:
0310-F2:GGGCCATACTTGTTGGATATCAT(SEQ ID NO.11);
0310-R2:TTGTTCATGGCGTAATGTCTCC(SEQ ID NO.12)。
example 2 Agrobacterium transformation and identification
Agrobacterium EHA105 competent cells preserved at-80 ℃ were added with 1. mu.l of the correctly sequenced pCA L Sm2 plasmid obtained in example 1, transformed by 1.8KV electric shock, spread on YEP plates containing kanamycin, rifampicin and streptomycin, cultured at 28 ℃ for about 48h, single colonies were picked up and shaken overnight, PCR verification of bacterial solutions was performed with specific primers (0310-F2 and 0310-R2) (see FIG. 2), fragments of about 900bp were obtained by amplification, positive clones (engineering Agrobacterium) were selected, shaken for 36-48h, and the bacterial solutions were preserved for infection.
Example 3 Critical concentration test of Bispyribac-sodium, imazapyr and imazethapyr in the seedling stage of ordinary rice
Bispyribac-sodium is a herbicide for rice fields, common rice has resistance to the bispyribac-sodium, so that the herbicide with a medicament specified concentration sprayed on the rice cannot cause damage to the rice, the safety concentration of most spraying is 30 mg/L, imazapyr is a nonselective sterilant herbicide, the common rice has no resistance to the common rice, the spraying concentration is recommended to be 95-98 mg/L, imazethapyr is an imidazolinone herbicide, is mainly used for preventing and killing gramineous weeds and broadleaf weeds in leguminous crops, has the advantages of strong selectivity, wide weed control spectrum, high activity and the like, the recommended concentration is 75 mg/L, and the common rice has weak resistance to the common rice.
This example analyzes the critical concentrations of rice resistance to Bispyribac-sodium, imazapyr and imazethapyr, and the results of experimental tests are shown in FIGS. 5,6 and 7. for Bispyribac-sodium, whether it is japonica rice mid-flower 11(ZH11) or indica rice 9311, 20 × (60 mg/m) is sprayed during the seedling stage2) Withering and dying above the concentration, selecting 90mg/m for testing the transgenic line with higher resistance2As the spraying concentration, the japonica rice middle flower 11(ZH11) is sprayed with the concentration of 0.5 × (49 mg/L) to wither and die in the seedling stage for the imazapyr, 2 × (196 mg/L) is selected as the spraying concentration for testing the transgenic line with higher resistance, and 20 × (1500 mg/L) is selected as the spraying concentration for the imazethapyr, the japonica rice middle flower 11(ZH11) is sprayed with the concentration of 5 × (375 mg/L) to wither and die in the seedling stage for testing the transgenic line with higher resistance.
Example 4 screening pressure test of callus period ZH11 Bispyribac-sodium
This example investigated the critical concentration of ZH11 for bispyribac-sodium resistance during callus period and the results are shown in FIG. 8. for bispyribac-sodium, callus proliferation was inhibited by adding 0.25. mu. mol/L or more to N6 medium.
EXAMPLE 5 Bispyribac-pCA L Sm2 genetic transformation System-Screen (1)
Taking rice as an example, the engineering agrobacterium obtained in the example 2 is used for transforming the callus of the rice Zhonghua 11(ZH11) by an agrobacterium-mediated genetic transformation method, after the callus is co-cultured for 3 days, the callus is washed for 5-6 times, transferred to a resistance screening culture medium containing bispyribac-sodium (N6+ 2.4-D2 mg/L + CH 0.6 g/L + Pro 0.5 g/L + sucrose 30 g/L + Phytagel 3 g/L + Cn 500 mg/L + bispyribac-sodium 0.6 mu mol/L), and dark cultured for 30-50 days at 30 ℃ to obtain the resistant callus through screening.
Example 6 Bispyribac-pCA L Sm2 genetic transformation System-Screen (2)
Taking rice as an example, the engineering agrobacterium obtained in the example 2 is used for transforming the callus of rice Zhonghua 11(ZH11) by an agrobacterium-mediated genetic transformation method, after co-culturing for 3 days, the callus is washed for 5-6 times, transferred to a culture medium containing bispyribac-sodium resistance selection (N6+ 2.4-D2.5 mg/L + CH 0.8-1 g/L + Pro 0.8 g/L + sucrose 30 g/L + Phytagel 3 g/L + Cn 500 mg/L + bispyribac-sodium 0.25 mu mol/L), and subjected to dark culture at 30 ℃ for 30-50 days to obtain resistant callus through selection.
Example 7 Bispyribac-pCA L Sm2 genetic transformation System-Screen (3)
Taking rice as an example, the engineering agrobacterium obtained in the example 2 is used for transforming the callus of the rice Zhonghua 11(ZH11) by an agrobacterium-mediated genetic transformation method, after the callus is co-cultured for 3 days, the callus is washed for 5-6 times, transferred to a screening medium containing bispyribac-sodium resistance (N6+ 2.4-D2 mg/L + CH 0.6 g/L + Pro 0.8 g/L + sucrose 30 g/L + Phytagel 3 g/L + Cn 500 mg/L + bispyribac-sodium 0.3 mu mol/L), and cultured in the dark at 30 ℃ for 30-50 days.
EXAMPLE 8 Bispyribac-pCA L Sm2 genetic transformation System-Screen (4)
Taking rice as an example, the engineered agrobacterium obtained in example 2 is transformed into calli of rice Zhonghua 11(ZH11) by agrobacterium-mediated genetic transformation, after co-culturing for 3 days, washed 5-6 times, transferred to a selection medium containing bispyribac-sodium resistance (N6+ 2.4-D2 mg/L + CH 0.6 g/L + Pro 0.5 g/L + sucrose 30 g/L + Phytagel 3 g/L + Cn 500 mg/L + bispyribac-sodium 0.4. mu. mol/L), dark cultured for 30-50 days at 30 ℃, and screened to obtain resistant calli (as shown in FIG. 9).
Example 9 Bispyribac-pCA L Sm2 genetic transformation System-Screen (5)
Taking rice as an example, the engineering agrobacterium obtained in the example 2 is used for transforming the callus of the rice Zhonghua 11(ZH11) by an agrobacterium-mediated genetic transformation method, after the callus is co-cultured for 3 days, the callus is washed for 5 to 6 times, transferred to a culture medium containing bispyribac-sodium resistance selection (N6+ 2.4-D2 mg/L + CH 0.8 g/L + Pro 0.5 g/L + sucrose 30 g/L + Phytagel 3 g/L + Cn 500 mg/L + bispyribac-sodium 0.5 mu mol/L), and dark cultured for 30 to 50 days at 30 ℃ to obtain the resistant callus through selection.
EXAMPLE 10 Bispyribac-pCA L Sm2 genetic transformation System-Screen (6)
Taking rice as an example, the engineering agrobacterium obtained in the example 2 is used for transforming the callus of rice Zhonghua 11(ZH11) by an agrobacterium-mediated genetic transformation method, after co-culturing for 3 days, the callus is washed for 5-6 times, transferred to a culture medium containing bispyribac-sodium resistance selection (N6+ 2.4-D2.5 mg/L + CH 0.6 g/L + Pro 0.5 g/L + sucrose 30 g/L + Phytagel 3 g/L + Cn 500 mg/L + bispyribac-sodium 0.8 mu mol/L), and dark cultured for 30-50 days at 30 ℃ to obtain resistant callus through selection.
EXAMPLE 11 Bispyribac-pCA L Sm2 genetic transformation System-Screen (7)
Taking rice as an example, the engineering agrobacterium obtained in the example 2 is used for transforming the callus of the rice Zhonghua 11(ZH11) by an agrobacterium-mediated genetic transformation method, after the callus is co-cultured for 3 days, the callus is washed for 5 to 6 times, transferred to a culture medium containing bispyribac resistance selection (N6+ 2.4-D2.5 mg/L + CH 0.6 g/L + Pro 0.5 g/L + sucrose 30 g/L + Phytagel 3 g/L + Cn 500 mg/L + bispyribac 1 mu mol/L), and dark cultured for 30 to 50 days at 30 ℃ to obtain the resistant callus through selection.
Example 12 pCA L Sm2 genetic transformation System-screening statistics
As a result of comparison of the positive rates of screening using bispyribac-sodium at different concentrations in examples 5 to 11 (see Table 1), it was found that more than 40% of positive calli were obtained when 0.3 to 0.4. mu. mol/L bispyribac-sodium was added to the screening medium, that the positive callus rate was decreased when the screening pressure was added at a low concentration, and that the positive callus rate was decreased when the screening pressure was added at a high concentration, presumably because the calli were completely inhibited with the increase in the screening pressure and thus positive calli could not be obtained, and therefore, it was found that it was preferable to add 0.3 to 0.4. mu. mol/L bispyribac-sodium to the screening medium, and it was more preferable to add 0.4. mu. mol/L bispyribac-sodium to obtain a good screening efficiency.
TABLE 1 statistics of screening results for bispyribac-sodium at different concentrations
Example 13 Bispyribac-pCA L Sm2 genetic transformation System-differentiation (1)
Transferring the obtained resistant callus to a bifenox-resistant differentiation medium (MS + KT 2 mg/L + NAA2 mg/L + sorbitol 30 g/L + sucrose 30 g/L + Phytagel 3 g/L + bifenox 0.05 mu mol/L), and differentiating for 25-30d to obtain a positive seedling.
EXAMPLE 14 Bispyribac-pCA L Sm2 genetic transformation System-differentiation (2)
The obtained resistant calli were transferred to a bifenox-resistant differentiation medium (MS + KT 2 mg/L + NAA2 mg/L + sorbitol 30 g/L + sucrose 30 g/L + Phytagel 3 g/L + bispyribac-0.1. mu. mol/L) and differentiated for 25-30d to obtain positive shoots (FIG. 10).
Example 15 Bispyribac-pCA L Sm2 genetic transformation System-differentiation (3)
Transferring the obtained resistant callus to a bifenox-resistant differentiation medium (MS + KT 2 mg/L + NAA2 mg/L + sorbitol 30 g/L + sucrose 30 g/L + Phytagel 3 g/L + bifenox 0.25 mu mol/L), and differentiating for 25-30d to obtain a positive seedling.
Example 16 Bispyribac-pCA L Sm2 genetic transformation System-differentiation (4)
Transferring the obtained resistant callus to a bifenox-resistant differentiation medium (MS + KT 2 mg/L + NAA1 mg/L + sorbitol 20 g/L + sucrose 30 g/L + Phytagel 3 g/L + bifenox 0.5 mu mol/L), and differentiating for 25-30d to obtain a positive seedling.
Example 17 Bispyribac-pCA L Sm2 genetic transformation System-differentiation (5)
Transferring the obtained resistant callus to a bifenox-resistant differentiation medium (MS + KT 2 mg/L + NAA1 mg/L + sorbitol 20 g/L + sucrose 30 g/L + Phytagel 3 g/L + bifenox 0.8 mu mol/L), and differentiating for 25-30d to obtain a positive seedling.
Example 18 Bispyribac-pCA L Sm2 genetic transformation System-differentiation (6)
Transferring the obtained resistant callus to a bifenox-resistant differentiation medium (MS + KT 2 mg/L + NAA1 mg/L + sorbitol 20 g/L + sucrose 30 g/L + Phytagel 3 g/L + bispyribac-1 mu mol/L), and differentiating for 25-30d to obtain a positive seedling.
EXAMPLE 19 Imazapyr-pCA L Sm2 genetic transformation System-differentiation (1)
Transferring the obtained resistant callus to a differentiation medium (MS + KT 2 mg/L + NAA2 mg/L + sorbitol 30 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazapyr 25 μ g/L) containing imazapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 20 Imazapyr-pCA L Sm2 genetic transformation System-differentiation (2)
The obtained resistant calli were transferred to a differentiating medium (MS + KT 2 mg/L + NAA2 mg/L + sorbitol 30 g/L + sucrose 30 g/L + Phytagel 3 g/L + Imazapyr 50. mu.g/L) containing resistance to Imazapyr, and differentiated for 25-30d to obtain positive seedlings (FIG. 10).
Example 21 Imazapyr-pCA L Sm2 genetic transformation System-differentiation (3)
Transferring the obtained resistant callus to a differentiation medium (MS + KT 2 mg/L + NAA2 mg/L + sorbitol 30 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazapyr 100 mu g/L) containing imazapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 22 Imazapyr-pCA L Sm2 genetic transformation System-differentiation (4)
Transferring the obtained resistant callus to a differentiating culture medium (MS + KT 2 mg/L + NAA1 mg/L + sorbitol 20 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazapyr 250 mug/L) containing imazapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 23 Imazapyr-pCA L Sm2 genetic transformation System-differentiation (5)
Transferring the obtained resistant callus to a differentiating culture medium (MS + KT 2 mg/L + NAA1 mg/L + sorbitol 20 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazapyr 375 mu g/L) containing imazapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 24 Imazapyr-pCA L Sm2 genetic transformation System-differentiation (6)
Transferring the obtained resistant callus to a differentiation medium (MS + KT 2 mg/L + NAA1 mg/L + sorbitol 20 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazapyr 500 mug/L) containing imazapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 25 Imazapyr-pCA L Sm2 genetic transformation System-differentiation (7)
Transferring the obtained resistant callus to a differentiating culture medium (MS + KT 2 mg/L + NAA0.5 mg/L + sorbitol 20 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazapyr 800 mu g/L) containing imazapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 26 Imazapyr-pCA L Sm2 genetic transformation System-differentiation (8)
Transferring the obtained resistant callus to a differentiating culture medium (MS + KT 2 mg/L + NAA0.5 mg/L + sorbitol 20 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazapyr 1000 mu g/L) containing imazapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 27 Imidazovinic acid-pCA L Sm2 genetic transformation System-differentiation (1)
Transferring the obtained resistant callus to a differentiation medium (MS + KT 2 mg/L + NAA2 mg/L + sorbitol 30 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazethapyr 25 mu g/L) containing imazethapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 28 Imidazovinic acid-pCA L Sm2 genetic transformation System-differentiation (2)
The obtained resistant calli were transferred to an imazethapyr resistant differentiation medium (MS + KT 2 mg/L + NAA2 mg/L + sorbitol 30 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazethapyr 50. mu.g/L) and differentiated for 25-30d to obtain positive shoots (FIG. 10).
Example 29 Imidazovinic acid-pCA L Sm2 genetic transformation System-differentiation (3)
Transferring the obtained resistant callus to a differentiation medium (MS + KT 2 mg/L + NAA2 mg/L + sorbitol 30 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazethapyr 100 mu g/L) containing imazethapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 30 Imidazovinic acid-pCA L Sm2 genetic transformation System-differentiation (4)
Transferring the obtained resistant callus to a differentiation medium (MS + KT 2 mg/L + NAA1 mg/L + sorbitol 20 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazethapyr 250 mu g/L) containing imazethapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 31 Imidazovinic acid-pCA L Sm2 genetic transformation System-differentiation (5)
Transferring the obtained resistant callus to a differentiation medium (MS + KT 2 mg/L + NAA1 mg/L + sorbitol 20 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazethapyr 375 mu g/L) containing imazethapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 32 Imidazovinic acid-pCA L Sm2 genetic transformation System-differentiation (6)
Transferring the obtained resistant callus to a differentiation medium (MS + KT 2 mg/L + NAA1 mg/L + sorbitol 20 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazethapyr 500 mu g/L) containing imazethapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 33 Imidazovinic acid-pCA L Sm2 genetic transformation System-differentiation (7)
Transferring the obtained resistant callus to a differentiation medium (MS + KT 2 mg/L + NAA0.5mg/L + sorbitol 20 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazethapyr 800 mu g/L) containing imazethapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 34 Imidazovinic acid-pCA L Sm2 genetic transformation System-differentiation (8)
Transferring the obtained resistant callus to a differentiation medium (MS + KT 2 mg/L + NAA0.5mg/L + sorbitol 20 g/L + sucrose 30 g/L + Phytagel 3 g/L + imazethapyr 1000 mu g/L) containing imazethapyr resistance, and differentiating for 25-30d to obtain a positive seedling.
Example 35 pCA L Sm2 genetic transformation System-statistics of differentiation
The comparison of the emergence rates of differentiation cultures with the different concentrations of bispyribac-sodium, imazapyr and imazethapyr added in examples 13-18, 19-26 and 27-34 (see tables 2, 3 and 4) shows that the addition of bispyribac-sodium, imazapyr or imazethapyr to the differentiation medium can inhibit the callus differentiation of ZH11, while the transgene positive callus has a higher differentiation rate, so that the addition of 0.05-0.25. mu. mol/L bispyribac, 30-100. mu.g/L imazapyr or 30-100. mu.g/L imazethapyr to the differentiation medium is preferred, and the addition of 0.1. mu. mol/L bispyribac, 50. mu.g/L imazethapyr or 50. mu.g/L imazethapyr can achieve a good differentiation efficiency when non-transgenosis is inhibited.
TABLE 2 statistics of the differentiation results of bispyribac-sodium at different concentrations
TABLE 3 statistics of differentiation results for imazapyr at different concentrations
TABLE 4 statistics of differentiation results for various concentrations of imazethapyr
In tables 2, 3 and 4, MSRe represents a differentiation medium without a screening agent, the components of the medium are shown in the summary of the invention, BS represents bispyribac-sodium, and BS0.05 represents the addition of bispyribac-sodium of 0.05 mu mol/L.
Example 36 Bispyribac-pCA L Sm2 genetic transformation System-rooting (1)
Transferring the positive seedlings obtained by differentiation to a rooting medium containing bispyribac-sodium resistance (1/2MS + sucrose 20 g/L + paclobutrazol 1 mg/L + Phytagel 3 g/L + bispyribac-sodium 0.05 mu mol/L), and finally obtaining positive transgenic plants.
Example 37 Bispyribac-pCA L Sm2 genetic transformation System-rooting (2)
The positive seedlings obtained by differentiation were transferred to rooting medium containing bispyribac-sodium resistance (1/2MS + sucrose 20 g/L + paclobutrazol 1 mg/L + Phytagel 3 g/L + bispyribac-sodium 0.1. mu. mol/L), and finally positive transgenic plants were obtained (FIG. 11).
Example 38 Bispyribac-pCA L Sm2 genetic transformation System-rooting (3)
Transferring the positive seedlings obtained by differentiation to a rooting medium containing bispyribac-sodium resistance (1/2MS + sucrose 20 g/L + paclobutrazol 1 mg/L + Phytagel 3 g/L + bispyribac-sodium 0.2 mu mol/L), and finally obtaining positive transgenic plants.
Example 39 Bispyribac-sodium L Sm2 genetic transformation System-rooting (4)
Transferring the positive seedlings obtained by differentiation to a rooting medium containing bispyribac-sodium resistance (1/2MS + sucrose 20 g/L + paclobutrazol 1 mg/L + Phytagel 3 g/L + bispyribac-sodium 0.3 mu mol/L), and finally obtaining positive transgenic plants.
Example 40 Bispyribac-pCA L Sm2 genetic transformation System-rooting (5)
The positive seedlings obtained by differentiation are transferred to a rooting medium containing bispyribac-sodium resistance (1/2MS + sucrose 20 g/L + paclobutrazol 1 mg/L + Phytagel 3 g/L + bispyribac-sodium 0.4 mu mol/L), and finally positive transgenic plants are obtained.
Example 41 Bispyribac-pCA L Sm2 genetic transformation System-rooting (6)
Transferring the positive seedlings obtained by differentiation to a rooting medium containing bispyribac-sodium resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.5 mg/L + Phytagel 3 g/L + bispyribac-sodium 0.5 mu mol/L), and finally obtaining positive transgenic plants.
Example 42 Bispyribac-sodium L Sm2 genetic transformation System-rooting (7)
The positive seedlings obtained by differentiation are transferred to a rooting medium containing bispyribac-sodium resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.5 mg/L + Phytagel 3 g/L + bispyribac-sodium 1 mu mol/L), and finally positive transgenic plants are obtained.
Example 43 Bispyribac-sodium L Sm2 genetic transformation System-rooting (8)
The positive seedlings obtained by differentiation are transferred to a rooting medium containing bispyribac-sodium resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.5 mg/L + Phytagel 3 g/L + bispyribac-sodium 3 mu mol/L), and finally positive transgenic plants are obtained.
Example 44 Bispyribac-pCA L Sm2 genetic transformation System-rooting (9)
The positive seedlings obtained by differentiation are transferred to a rooting medium containing bispyribac-sodium resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.8 mg/L + Phytagel 3 g/L + bispyribac-sodium 5 mu mol/L), and finally positive transgenic plants are obtained.
Example 45 Bispyribac-pCA L Sm2 genetic transformation System-rooting (10)
The positive seedlings obtained by differentiation are transferred to a rooting medium containing bispyribac-sodium resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.8 mg/L + Phytagel 3 g/L + bispyribac-sodium 10 mu mol/L), and finally positive transgenic plants are obtained.
Example 46 Imazapyr-pCA L Sm2 genetic transformation System-rooting (1)
The positive seedlings obtained by differentiation are transferred to a rooting medium containing imazapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 1 mg/L + Phytagel 3 g/L + imazapyr 25 mug/L), and finally positive transgenic plants are obtained.
Example 47 Imazapyr-pCA L Sm2 genetic transformation System-rooting (2)
The positive seedlings obtained by differentiation were transferred to rooting medium containing imazapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 1 mg/L + Phytagel 3 g/L + imazapyr 50. mu.g/L), and finally positive transgenic plants were obtained (FIG. 11).
Example 48 Imazapyr-pCA L Sm2 genetic transformation System-rooting (3)
The positive seedlings obtained by differentiation are transferred to a rooting medium containing imazapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 1 mg/L + Phytagel 3 g/L + imazapyr 100 mu g/L), and finally positive transgenic plants are obtained.
Example 49 Imazapyr-pCA L Sm2 genetic transformation System-rooting (4)
The positive seedlings obtained by differentiation are transferred to a rooting culture medium containing imazapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.5 mg/L + Phytagel 3 g/L + imazapyr 250 mu g/L), and finally positive transgenic plants are obtained.
Example 50 Imazapyr-pCA L Sm2 genetic transformation System-rooting (5)
The positive seedlings obtained by differentiation are transferred to a rooting culture medium containing imazapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.5 mg/L + Phytagel 3 g/L + imazapyr 375 mu g/L), and finally positive transgenic plants are obtained.
Example 51 Imazapyr-pCA L Sm2 genetic transformation System-rooting (6)
The positive seedlings obtained by differentiation are transferred to a rooting culture medium containing imazapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.5 mg/L + Phytagel 3 g/L + imazapyr 500 mu g/L), and finally positive transgenic plants are obtained.
Example 52 Imazapyr-pCA L Sm2 genetic transformation System-rooting (7)
The positive seedlings obtained by differentiation are transferred to a rooting culture medium containing imazapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.8 mg/L + Phytagel 3 g/L + imazapyr 625 mu g/L), and finally positive transgenic plants are obtained.
Example 53 Imazapyr-pCA L Sm2 genetic transformation System-rooting (8)
The positive seedlings obtained by differentiation are transferred to a rooting culture medium containing imazapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.8 mg/L + Phytagel 3 g/L + imazapyr 1000 mu g/L), and finally positive transgenic plants are obtained.
Example 54 Imidazovinic acid-pCA L Sm2 genetic transformation System-rooting (1)
The positive seedlings obtained by differentiation are transferred to rooting culture medium (1/2MS + sucrose 20 g/L + paclobutrazol 1 mg/L + Phytagel 3 g/L + imazethapyr 25 mug/L) containing imazethapyr resistance, and finally positive transgenic plants are obtained.
Example 55 Imidazovinic acid-pCA L Sm2 genetic transformation System-rooting (2)
The positive seedlings obtained by differentiation were transferred to rooting medium containing imazethapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 1 mg/L + Phytagel 3 g/L + imazethapyr 50. mu.g/L), and finally positive transgenic plants were obtained (FIG. 11).
Example 56 Imidazovinic acid-pCA L Sm2 genetic transformation System-rooting (3)
The positive seedlings obtained by differentiation are transferred to rooting culture medium containing imazethapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 1 mg/L + Phytagel 3 g/L + imazethapyr 100 mu g/L), and finally positive transgenic plants are obtained.
Example 57 Imidazovinic acid-pCA L Sm2 genetic transformation System-rooting (4)
The positive seedlings obtained by differentiation are transferred to rooting culture medium containing imazethapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.5 mg/L + Phytagel 3 g/L + imazethapyr 250 mu g/L), and finally positive transgenic plants are obtained.
Example 58 Imidazovinic acid-pCA L Sm2 genetic transformation System-rooting (5)
The positive seedlings obtained by differentiation are transferred to rooting culture medium containing imazethapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.5 mg/L + Phytagel 3 g/L + imazethapyr 375 mu g/L), and finally positive transgenic plants are obtained.
Example 59 Imidazovinic acid-pCA L Sm2 genetic transformation System-rooting (6)
The positive seedlings obtained by differentiation are transferred to rooting culture medium containing imazethapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.5 mg/L + Phytagel 3 g/L + imazethapyr 500 mu g/L), and finally positive transgenic plants are obtained.
Example 60 Imidazovinic acid-pCA L Sm2 genetic transformation System-rooting (7)
The positive seedlings obtained by differentiation are transferred to rooting culture medium containing imazethapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.8 mg/L + Phytagel 3 g/L + imazethapyr 625 mu g/L), and finally positive transgenic plants are obtained.
Example 61 Imidazovinic acid-pCA L Sm2 genetic transformation System-rooting (8)
The positive seedlings obtained by differentiation are transferred to rooting culture medium containing imazethapyr resistance (1/2MS + sucrose 20 g/L + paclobutrazol 0.8 mg/L + Phytagel 3 g/L + imazethapyr 1000 mug/L), and finally positive transgenic plants are obtained.
Example 62 pCA L Sm2 genetic transformation System-rooting statistics
The comparison of the rooting survival rates of rooting cultures with the bispyribac-sodium, imazapyr and imazethapyr added in different concentrations in examples 36-45, 46-53 and 54-61 (see tables 5,6 and 7) shows that the rooting culture medium added with 0.05-10 μmol/L bispyribac or 25-1000 μ g/L imazapyr or 25-1000 μ g/L imazethapyr can inhibit the survival of differentiated seedlings of ZH11, while the survival rate of most transgenic positive differentiated seedlings reaches more than 80% respectively.
TABLE 5 Bispyribac-sodium rooting results statistics for different concentrations
TABLE 6 statistics of rooting results for imazapyr of different concentrations
TABLE 7 statistics of rooting results for imazethapyr at different concentrations
Example 63 transgenic line identification
In order to identify whether the obtained line is a transgenic line, this example performed PCR verification of a partially positive transgenic plant obtained by screening culture, differentiation culture and rooting culture.
Firstly, extracting sample DNA, the DNA extraction step is that rice leaves with the length of about 2cm are placed in a 2ml centrifuge tube, 800 mul of 1.5 × CTAB is added into a mortar, the leaves are ground to be homogenized and poured back into the centrifuge tube, water bath at 65 ℃ is carried out for 20-30min, the mixture is evenly mixed for 1 time every 5min, centrifugation is carried out at 12000rpm for 10min, 400 mul of supernatant is absorbed into a new centrifuge tube, 2 times of absolute ethyl alcohol with ice precooling by volume is added, ice is placed at 20 ℃ for 20min, centrifugation is carried out at 12000rpm for 10min, supernatant is abandoned, 500 mul of 75 percent ethyl alcohol is added, the mixture is reversely rinsed, centrifugation is carried out at 8000rpm for 5min, the supernatant is abandoned, the mixture is placed on a super clean bench to be dried by blowing2O dissolves the DNA.
In order to distinguish endogenous genes of rice, a pair of primers (0310-F4/0310-R4) is designed to carry out PCR amplification detection on a genomic DNA sample of a transgenic strain, the primers cannot amplify a fragment by taking the endogenous rice genome as a template, and the size of the fragment amplified by taking a transgenic expression cassette as the template is about 670 bp.
The primer sequences are as follows:
0310-F4:CATTGAGAACCTCCCTGTG(SEQ ID NO.13);
0310-R4:GACAAATTTGTTTGTCAGATCAA(SEQ ID NO.14)。
plasmid DNA for transformation was used as a positive control, and ZH11 genomic DNA was used as a negative control.
The PCR reaction procedure was as follows: pre-denaturation at 94 deg.C for 5min, denaturation at 94 deg.C for 45s, and annealing at 55-65 deg.C for 45 s; extending for 1.5min at 72 ℃; 30-35 cycles; further extension for 10min at 72 ℃; and finishing at 16 ℃.
The PCR reaction system is as follows:
the PCR product was electrophoresed on an agarose gel, and the results are shown in FIG. 12. Electrophoresis results show that most of transgenic samples contain about 670bp of transgenic bands, and the sizes of the transgenic bands are the same as those of the vector control; while the negative control ZH11 failed to produce a band.
Example 64 resistance phenotype identification
Selecting part of rooting material, transplanting for 7-14 days (about 3-5 leaf stage), spraying 90mg/m2Bispyribac-sodium (a, b of FIG. 13). After 3-7 days of spraying, the wild type has withered and yellow leaves. After 7 days, the wild-type control ZH11 had died of yellow, and most plants of the transgenic lines grew normally, with yellowing appearing in part. After 14 days, the wild-type control ZH11 and the transgenic sensitive line had completely died, and the surviving line was the bispyribac-sodium resistant line (c, d of FIG. 13).
After a part of rooting materials are selected and transplanted for 7-14 days (about 3-5 leaf stage), 196 mg/L imazapyr (e in figure 13) is sprayed, after 21 days, wild type control ZH11, 9311 or MH63 shows withered yellow, withered or dead to different degrees, but the transgenic positive line grows normally, and the survival line is an imazapyr resistant line (f in figure 13).
After a part of rooting materials are selected and transplanted for 7-14 days (about 3-5 leaf stage), 1500 mg/L imazethapyr (g in figure 13) is sprayed, after 21 days, wild type control ZH11, 9311 or MH63 shows withered yellow, withered or dead to different degrees, but the transgenic positive line grows normally, and the survival line is an imazethapyr resistant line (h in figure 13).
The results show that the transgenic line obtained by screening has high resistance to bispyribac-sodium, imazapyr and imazethapyr. The three herbicides are only representatives of the herbicide classes, and the obtained transgenic line not only has high resistance of the three herbicides, but also has high resistance of other sulfonylurea herbicides, imidazolinones herbicides and pyrimidine salicylic acid herbicides such as bensulfuron-methyl, chlorsulfuron, pyrithiobac-sodium and the like.
The results show that the application successfully establishes a genetic transformation full-term screening system based on the bispyribac-sodium/imazapyr/imazethapyr-A L Sm2 screening marker, and can be used for rice genetic transformation.
The pCA L Sm2 obtained by the invention is used as a plant binary expression vector, and can enter the vector through cloning other expression cassettes to carry out genetic transformation to obtain corresponding characters, such as a fluorescent protein expression cassette, a GUS reporter gene expression cassette, an insect-resistant expression cassette, an herbicide-resistant expression cassette, other functional genes and the like.
Although the invention has been described in detail hereinabove with respect to a general description and specific embodiments thereof, it will be apparent to those skilled in the art that modifications or improvements may be made thereto based on the invention. Accordingly, such modifications and improvements are intended to be within the scope of the invention as claimed.
Sequence listing
<110> Hainan Borax Rice Gene science and technology Co., Ltd
<120> rice A L S mutant gene, plant transgenic screening vector pCA L Sm2 containing gene and application thereof
<130>KHP201110923.9
<160>14
<170>SIPOSequenceListing 1.0
<210>1
<211>644
<212>PRT
<213> Artificial Sequence (Artificial Sequence)
<400>1
Met Ala Thr Thr Ala Ala Ala Ala Ala Ala Ala Leu Ser Ala Ala Ala
1 5 10 15
Thr Ala Lys Thr Gly Arg Lys Asn His Gln Arg His His Val Leu Pro
20 25 30
Ala Arg Gly Arg Val Gly Ala Ala Ala Val Arg Cys Ser Ala Val Ser
35 40 45
Pro Val Thr Pro Pro Ser Pro Ala Pro Pro Ala Thr Pro Leu Arg Pro
50 55 60
Trp Gly Pro Ala Glu Pro Arg Lys Gly Ala Asp Ile Leu Val Glu Ala
65 70 75 80
Leu Glu Arg Cys Gly Val Ser Asp Val Phe Ala Tyr Pro Gly Ala Ala
85 90 95
Ser Met Glu Ile His Gln Ala Leu Thr Arg Ser Pro Val Ile Thr Asn
100 105 110
His Leu Phe Arg His Glu Gln Gly Glu Ala Phe Ala Ala Ser Gly Tyr
115 120 125
Ala Arg Ala Ser Gly Arg Val Gly Val Cys Val Ala Thr Ser Gly Pro
130 135140
Gly Ala Thr Asn Leu Val Ser Ala Leu Ala Asp Ala Leu Leu Asp Ser
145 150 155 160
Val Pro Met Val Ala Ile Thr Gly Gln Val Pro Arg Arg Met Ile Gly
165 170 175
Thr Asp Ala Phe Gln Glu Thr Pro Ile Val Glu Val Thr Arg Ser Ile
180 185 190
Thr Lys His Asn Tyr Leu Val Leu Asp Val Glu Asp Ile Pro Arg Val
195 200 205
Ile Gln Glu Ala Phe Phe Leu Ala Ser Ser Gly Arg Pro Gly Pro Val
210 215 220
Leu Val Asp Ile Pro Lys Asp Ile Gln Gln Gln Met Ala Val Pro Val
225 230 235 240
Trp Asp Thr Ser Met Asn Leu Pro Gly Tyr Ile Ala Arg Leu Pro Lys
245 250 255
Pro Pro Ala Thr Glu Leu Leu Glu Gln Val Leu Arg Leu Val Gly Glu
260 265 270
Ser Arg Arg Pro Ile Leu Tyr Val Gly Gly Gly Cys Ser Ala Ser Gly
275 280 285
Asp Glu Leu Arg Trp Phe Val Glu Leu Thr Gly Ile Pro Val Thr Thr
290 295 300
Thr Leu Met Gly Leu Gly Asn Phe Pro Ser Asp Asp Pro Leu Ser Leu
305 310 315 320
Arg Met Leu Gly Met His Gly Thr Val Tyr Ala Asn Tyr Ala Val Asp
325 330 335
Lys Ala Asp Leu Leu Leu Ala Phe Gly Val Arg Phe Asp Asp Arg Val
340 345 350
Thr Gly Lys Ile Glu Ala Phe Ala Ser Arg Ala Lys Ile Val His Ile
355 360 365
Asp Ile Asp Pro Ala Glu Ile Gly Lys Asn Lys Gln Pro His Val Ser
370 375 380
Ile Cys Ala Asp Val Lys Leu Ala Leu Gln Gly Leu Asn Ala Leu Leu
385 390 395 400
Gln Gln Ser Thr Thr Lys Thr Ser Ser Asp Phe Ser Ala Trp His Asn
405 410 415
Glu Leu Asp Gln Gln Lys Arg Glu Phe Pro Leu Gly Tyr Lys Thr Phe
420 425 430
Gly Glu Glu Ile Pro Pro Gln Tyr Ala Ile Gln Val Leu Asp Glu Leu
435 440 445
Thr Lys Gly Glu Ala Ile Ile Ala Thr Gly Val Gly Gln His Gln Met
450 455 460
Trp Ala Ala Gln Tyr Tyr Thr Tyr Lys Arg Pro Arg Gln Trp Leu Ser
465 470 475 480
Ser Ala Gly Leu Gly Ala Met Gly Phe Gly Leu Pro Ala Ala Ala Gly
485 490 495
Ala Ser Val Ala Asn Pro Gly Val Thr Val Val Asp Ile Asp Gly Asp
500 505 510
Gly Ser Phe Leu Met Asn Ile Gln Glu Leu Ala Leu Ile Arg Ile Glu
515 520 525
Asn Leu Pro Val Lys Val Met Val Leu Asn Asn Gln His Leu Gly Met
530 535 540
Val Val Gln Leu Glu Asp Arg Phe Tyr Lys Ala Asn Arg Ala His Thr
545 550 555 560
Tyr Leu Gly Asn Pro Glu Cys Glu Ser Glu Ile Tyr Pro Asp Phe Val
565 570 575
Thr Ile Ala Lys Gly Phe Asn Ile Pro Ala Val Arg Val Thr Lys Lys
580 585 590
Ser Glu Val Arg Ala Ala Ile Lys Lys Met Leu Glu Thr Pro Gly Pro
595 600 605
Tyr Leu Leu Asp Ile Ile Val Pro His Gln Glu His Val Leu Pro Met
610 615 620
Ile Pro Ile Gly Gly Ala Phe Lys Asp Met Ile Leu Asp Gly Asp Gly
625 630 635 640
Arg Thr Val Tyr
<210>2
<211>1935
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>2
atggctacga ccgccgcggc cgcggccgcc gccctgtccg ccgccgcgac ggccaagacc 60
ggccgtaaga accaccagcg acaccacgtc cttcccgctc gaggccgggt gggggcggcg 120
gcggtcaggt gctcggcggt gtccccggtc accccgccgt ccccggcgcc gccggccacg 180
ccgctccggc cgtgggggcc ggccgagccc cgcaagggcg cggacatcct cgtggaggcg 240
ctggagcggt gcggcgtcag cgacgtgttc gcctacccgg gcgccgcgtc catggagatc 300
caccaggcgc tgacgcgctc cccggtcatc accaaccacc tcttccgcca cgagcagggc 360
gaggcgttcg cggcgtccgg gtacgcgcgc gcgtccggcc gcgtcggggt ctgcgtcgcc 420
acctccggcc ccggggcaac caacctcgtg tccgcgctcg ccgacgcgct gctcgactcc 480
gtcccgatgg tcgccatcac gggccaggtc ccccgccgca tgatcggcac cgacgccttc 540
caggagacgc ccatagtcga ggtcacccgc tccatcacca agcacaatta ccttgtcctt 600
gatgtggagg acatcccccg cgtcatacag gaagccttct tcctcgcgtc ctcgggccgt 660
cctggcccgg tgctggtcga catccccaag gacatccagc agcagatggc cgtgccggtc 720
tgggacacct cgatgaatct accagggtac atcgcacgcc tgcccaagcc acccgcgaca 780
gaattgcttg agcaggtctt gcgtctggtt ggcgagtcac ggcgcccgat tctctatgtc 840
ggtggtggct gctctgcatc tggtgacgaa ttgcgctggt ttgttgagct gactggtatc 900
ccagttacaa ccactctgat gggcctcggc aatttcccca gtgacgaccc gttgtccctg 960
cgcatgcttg ggatgcatgg cacggtgtac gcaaattatg ccgtggataa ggctgacctg 1020
ttgcttgcgt ttggtgtgcg gtttgatgat cgtgtgacag ggaaaattga ggcttttgca 1080
agcagggcca agattgtgca cattgacatt gatccagcag agattggaaa gaacaagcaa 1140
ccacatgtgt caatttgcgc agatgttaag cttgctttac agggcttgaa tgctctgcta 1200
caacagagca caacaaagac aagttctgat tttagtgcat ggcacaatga gttggaccag 1260
cagaagaggg agtttcctct ggggtacaaa acttttggtg aagagatccc accgcaatat 1320
gccattcagg tgctggatga gctgacgaaa ggtgaggcaa tcatcgctac tggtgttggg 1380
cagcaccaga tgtgggcggc acaatattac acctacaagc ggccacggca gtggctgtct 1440
tcggctggtc tgggcgcaat gggatttggg ctgcctgctg cagctggtgc ttctgtggct 1500
aacccaggtg tcacagttgt tgatattgat ggggatggta gcttcctcat gaacattcag 1560
gagctggcat tgatccgcat tgagaacctc cctgtgaagg tgatggtgtt gaacaaccaa 1620
catttgggta tggtggtgca attggaggat aggttttaca aggcgaatag ggcgcataca 1680
tacttgggca acccggaatg tgagagcgag atatatccag attttgtgac tattgctaag 1740
gggttcaata ttcctgcagt ccgtgtaaca aagaagagtg aagtccgtgc cgccatcaag 1800
aagatgctcg agactccagg gccatacttg ttggatatca tcgtcccgca ccaggagcat 1860
gtgctgccta tgatcccaat tgggggcgca ttcaaggaca tgatcctgga tggtgatggc 1920
aggactgtgt attaa 1935
<210>3
<211>4431
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>3
cgtaaagtct tcactcctcc ccctttctct ctagttagcg gagacatgac aaccagtcat 60
ccgattaggt ttatagtggc attgcaagca gtcagcaaat gaataaatga aagaggcaat 120
cttcatggtc ctcttcatct tgtctcacat gcgagttgat tttagaccaa cacggtaact 180
caggggataa aatagatttg ttacaaattt ccaataagta agattccatg aaattggtga 240
tagtatataa tgattttatt gcacaagcta tgcattgcag ctactgattc aacactattc 300
agaaaaaaaa agaacaagtg tatttctggt aaaactgttc cattcaaaat ctagtccacg 360
actagtccat gatttggtcg tgtgaaaaca atggatgcac tatatagtct ctagtactat 420
tctattgtac taagcactat atatagtatt ataaactacg gtttatggag tagccagcaa 480
gacaataagt taacaagaaa taaatttaaa gtactaaaca caataagcca attagcatgg 540
tgaaatgatg atttgctatg actaatctac gactaattgt gcgacttgct atttggtcga 600
gtcgtagccc tctagtcgtc tgacttgact gacgttatga ctagtctacg acttgataac 660
agcgatccag atgtcttaag tgatgaggag aagaaagaac taccagaaag taaaccttat 720
atgcatagtt acatacacag gtacacttcc gaaggcccca atcaatggaa taccatatgc 780
tcttattagg ctattatatg gttctgggta acaattaaat atatcatggg tgtaccgcca 840
atgtgaaatt gagaactgca tacacatagc cacattataa aatataaatg cactatgctc 900
ctgatcatgg aatgccaacc ccttattatc aaacccaaag aagggaaatc cctttctatc 960
tcaagcatgc acaattacct ttgtttagca taaatctatc aaatattgca atgcaaacct 1020
taagcacaga tgtcctccct cttaaatatt aatcataatc ctcagtaaat ggacatacag 1080
cataaagtac tttaaattac cataggttga attggaaata ttctttttag tagctcacag 1140
aaaaatgggt actaaaacta actattagta aacataaaag ccccttaatg ataggagggc 1200
tctacacaag acagtcagta gcatgataac cacctacaat gttgttccta caaataaaaa 1260
tactgtagca atctcttact aagttaaaac atactgaggt tctagggttt aaccataagt 1320
aattagaata tcaaaatagc tcaagattag agaaggtcct acagaaaaac acggttatct 1380
gcttctcaaa tggcctagct acaccgggca ctagcaggat cttaaacagc actaaaataa 1440
gtatctccct tggtcatcaa atcgaaaaga aaatcctaca gagtccacgc ctttccttcc 1500
ccccactaat taacgaaaag aaacgcagag ttccaattaa ggagaaagag atacggggta 1560
caacaaacat cgcattcgtc tcgtgctagg gttttcggga ggcgggtcta gggttgaggc 1620
aaaaaggggg agggaattga gcagggggtt accgcggtag tcgacgccgg agttgagctt 1680
gacgacgacg gggcgccccc tgatggactt gaggaagtcg gagggcgtct tcaccgcccc 1740
gccgccgccg ccaccgccgc cgccgcccga gccggacttc tcgccgccac tgctcatctt 1800
gcgctgcgtt tgtgcgggtg cgggtgcggg tgctagactg ctaggtctcg cggttgcatc 1860
cgcatccgac tttgagatcg attttttatc gggttctgta ccctccaccc gttattggga 1920
ctgacccacc tgtcatcctc atccaatcga ctgacacgcg ggcccagatc gaccccgacg 1980
tggctgtgtg tcatcctatc ccaccgacat atggggccca ctgtgacgtg gccccacacg 2040
atcccatccg agccacacat cgcctcacgc tgcgtcaccg cgcgcggaca aaacacccac 2100
acccccacac tctccacccc tctctccctc tcgcccaaac ccagaaaccc tcgccgccgc 2160
cgccgccgcc accacccacc atggctacga ccgccgcggc cgcggccgcc gccctgtccg 2220
ccgccgcgac ggccaagacc ggccgtaaga accaccagcg acaccacgtc cttcccgctc 2280
gaggccgggt gggggcggcg gcggtcaggt gctcggcggt gtccccggtc accccgccgt 2340
ccccggcgcc gccggccacg ccgctccggc cgtgggggcc ggccgagccc cgcaagggcg 2400
cggacatcct cgtggaggcg ctggagcggt gcggcgtcag cgacgtgttc gcctacccgg 2460
gcgccgcgtc catggagatc caccaggcgc tgacgcgctc cccggtcatc accaaccacc 2520
tcttccgcca cgagcagggc gaggcgttcg cggcgtccgg gtacgcgcgc gcgtccggcc 2580
gcgtcggggt ctgcgtcgcc acctccggcc ccggggcaac caacctcgtg tccgcgctcg 2640
ccgacgcgct gctcgactcc gtcccgatgg tcgccatcac gggccaggtc ccccgccgca 2700
tgatcggcac cgacgccttc caggagacgc ccatagtcga ggtcacccgc tccatcacca 2760
agcacaatta ccttgtcctt gatgtggagg acatcccccg cgtcatacag gaagccttct 2820
tcctcgcgtc ctcgggccgt cctggcccgg tgctggtcga catccccaag gacatccagc 2880
agcagatggc cgtgccggtc tgggacacct cgatgaatct accagggtac atcgcacgcc 2940
tgcccaagcc acccgcgaca gaattgcttg agcaggtctt gcgtctggtt ggcgagtcac 3000
ggcgcccgattctctatgtc ggtggtggct gctctgcatc tggtgacgaa ttgcgctggt 3060
ttgttgagct gactggtatc ccagttacaa ccactctgat gggcctcggc aatttcccca 3120
gtgacgaccc gttgtccctg cgcatgcttg ggatgcatgg cacggtgtac gcaaattatg 3180
ccgtggataa ggctgacctg ttgcttgcgt ttggtgtgcg gtttgatgat cgtgtgacag 3240
ggaaaattga ggcttttgca agcagggcca agattgtgca cattgacatt gatccagcag 3300
agattggaaa gaacaagcaa ccacatgtgt caatttgcgc agatgttaag cttgctttac 3360
agggcttgaa tgctctgcta caacagagca caacaaagac aagttctgat tttagtgcat 3420
ggcacaatga gttggaccag cagaagaggg agtttcctct ggggtacaaa acttttggtg 3480
aagagatccc accgcaatat gccattcagg tgctggatga gctgacgaaa ggtgaggcaa 3540
tcatcgctac tggtgttggg cagcaccaga tgtgggcggc acaatattac acctacaagc 3600
ggccacggca gtggctgtct tcggctggtc tgggcgcaat gggatttggg ctgcctgctg 3660
cagctggtgc ttctgtggct aacccaggtg tcacagttgt tgatattgat ggggatggta 3720
gcttcctcat gaacattcag gagctggcat tgatccgcat tgagaacctc cctgtgaagg 3780
tgatggtgtt gaacaaccaa catttgggta tggtggtgca attggaggat aggttttaca 3840
aggcgaatag ggcgcataca tacttgggca acccggaatg tgagagcgag atatatccag 3900
attttgtgac tattgctaag gggttcaata ttcctgcagt ccgtgtaaca aagaagagtg 3960
aagtccgtgc cgccatcaag aagatgctcg agactccagg gccatacttg ttggatatca 4020
tcgtcccgca ccaggagcat gtgctgccta tgatcccaat tgggggcgca ttcaaggaca 4080
tgatcctgga tggtgatggc aggactgtgt attaatctag agtcctcagc catagagctg 4140
ctgctgttct agggttcaca agtctgccta tttgtcttcc ccaatggagc tatggttgtc 4200
tggtctggtc cttggtcgtg tcccgtttca ttgtgtacta tttacctgta atgtgtatcc 4260
ttaagtctgg tttgatggtg tctgaaacgt tttgctgtgg tagagcagca tggaagaact 4320
ataatgaata agtgatccct aatcattgtg tccaaatttt gcttctgcta tacccttttg 4380
tgctgtttct tatgttttgc ttaaaaattt gatctgacaa acaaatttgt c 4431
<210>4
<211>10933
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>4
ctgcaggccc gggcagcgct gaagaacttc cctaggcacg tgtacgtatt ttttaccagg 60
tgaactccaa gtcctggacc cttttttaag cttagattgt cgtttcccgc cttcagttta 120
aactatcagt gtttgacagg atatattggc gggtaaacct aagagaaaag agcgtttatt 180
agaataacgg atatttaaaa gggcgtgaaa aggtttatcc gttcgtccat ttgtatgtgc 240
atgccaacca cagggttccc ctcgggatca aagtactttg atccaacccc tccgctgcta 300
tagtgcagtc ggcttctgac gttcagtgca gccgtcttct gaaaacgaca tgtcgcacaa 360
gtcctaagtt acgcgacagg ctgccgccct gcccttttcc tggcgttttc ttgtcgcgtg 420
ttttagtcgc ataaagtaga atacttgcga ctagaaccgg agacattacg ccatgaacaa 480
gagcgccgcc gctggcctgc tgggctatgc ccgcgtcagc accgacgacc aggacttgac 540
caaccaacgg gccgaactgc acgcggccgg ctgcaccaag ctgttttccg agaagatcac 600
cggcaccagg cgcgaccgcc cggagctggc caggatgctt gaccacctac gccctggcga 660
cgttgtgaca gtgaccaggc tagaccgcct ggcccgcagc acccgcgacc tactggacat 720
tgccgagcgc atccaggagg ccggcgcggg cctgcgtagc ctggcagagc cgtgggccga 780
caccaccacg ccggccggcc gcatggtgtt gaccgtgttc gccggcattg ccgagttcga 840
gcgttcccta atcatcgacc gcacccggag cgggcgcgag gccgccaagg cccgaggcgt 900
gaagtttggc ccccgcccta ccctcacccc ggcacagatc gcgcacgccc gcgagctgat 960
cgaccaggaa ggccgcaccg tgaaagaggc ggctgcactg cttggcgtgc atcgctcgac 1020
cctgtaccgc gcacttgagc gcagcgagga agtgacgccc accgaggcca ggcggcgcgg 1080
tgccttccgt gaggacgcat tgaccgaggc cgacgccctg gcggccgccg agaatgaacg 1140
ccaagaggaa caagcatgaa accgcaccag gacggccagg acgaaccgtt tttcattacc 1200
gaagagatcg aggcggagat gatcgcggcc gggtacgtgt tcgagccgcc cgcgcacgtc 1260
tcaaccgtgc ggctgcatga aatcctggcc ggtttgtctg atgccaagct ggcggcctgg 1320
ccggccagct tggccgctga agaaaccgag cgccgccgtc taaaaaggtg atgtgtattt 1380
gagtaaaaca gcttgcgtca tgcggtcgct gcgtatatga tgcgatgagt aaataaacaa 1440
atacgcaagg ggaacgcatg aaggttatcg ctgtacttaa ccagaaaggc gggtcaggca 1500
agacgaccat cgcaacccat ctagcccgcg ccctgcaact cgccggggcc gatgttctgt 1560
tagtcgattc cgatccccag ggcagtgccc gcgattgggc ggccgtgcgg gaagatcaac 1620
cgctaaccgt tgtcggcatc gaccgcccga cgattgaccg cgacgtgaag gccatcggcc 1680
ggcgcgactt cgtagtgatc gacggagcgc cccaggcggc ggacttggct gtgtccgcga 1740
tcaaggcagc cgacttcgtg ctgattccgg tgcagccaag cccttacgac atatgggcca 1800
ccgccgacct ggtggagctg gttaagcagc gcattgaggt cacggatgga aggctacaag 1860
cggcctttgt cgtgtcgcgg gcgatcaaag gcacgcgcat cggcggtgag gttgccgagg 1920
cgctggccgg gtacgagctg cccattcttg agtcccgtat cacgcagcgc gtgagctacc 1980
caggcactgc cgccgccggc acaaccgttc ttgaatcaga acccgagggc gacgctgccc 2040
gcgaggtcca ggcgctggcc gctgaaatta aatcaaaact catttgagtt aatgaggtaa 2100
agagaaaatg agcaaaagca caaacacgct aagtgccggc cgtccgagcg cacgcagcag 2160
caaggctgca acgttggcca gcctggcaga cacgccagcc atgaagcggg tcaactttca 2220
gttgccggcg gaggatcaca ccaagctgaa gatgtacgcg gtacgccaag gcaagaccat 2280
taccgagctg ctatctgaat acatcgcgca gctaccagag taaatgagca aatgaataaa 2340
tgagtagatg aattttagcg gctaaaggag gcggcatgga aaatcaagaa caaccaggca 2400
ccgacgccgt ggaatgcccc atgtgtggag gaacgggcgg ttggccaggc gtaagcggct 2460
gggttgtctg ccggccctgc aatggcactg gaacccccaa gcccgaggaa tcggcgtgac 2520
ggtcgcaaac catccggccc ggtacaaatc ggcgcggcgc tgggtgatga cctggtggag 2580
aagttgaagg ccgcgcaggc cgcccagcgg caacgcatcg aggcagaagc acgccccggt 2640
gaatcgtggc aagcggccgc tgatcgaatc cgcaaagaat cccggcaacc gccggcagcc 2700
ggtgcgccgt cgattaggaa gccgcccaag ggcgacgagc aaccagattt tttcgttccg 2760
atgctctatg acgtgggcac ccgcgatagt cgcagcatca tggacgtggc cgttttccgt 2820
ctgtcgaagc gtgaccgacg agctggcgag gtgatccgct acgagcttcc agacgggcac 2880
gtagaggttt ccgcagggcc ggccggcatg gccagtgtgt gggattacga cctggtactg 2940
atggcggttt cccatctaac cgaatccatg aaccgatacc gggaagggaa gggagacaag 3000
cccggccgcg tgttccgtcc acacgttgcg gacgtactca agttctgccg gcgagccgat 3060
ggcggaaagc agaaagacga cctggtagaa acctgcattc ggttaaacac cacgcacgtt 3120
gccatgcagc gtacgaagaa ggccaagaac ggccgcctgg tgacggtatc cgagggtgaa 3180
gccttgatta gccgctacaa gatcgtaaag agcgaaaccg ggcggccgga gtacatcgag 3240
atcgagctag ctgattggat gtaccgcgag atcacagaag gcaagaaccc ggacgtgctg 3300
acggttcacc ccgattactt tttgatcgat cccggcatcg gccgttttct ctaccgcctg 3360
gcacgccgcg ccgcaggcaa ggcagaagcc agatggttgt tcaagacgat ctacgaacgc 3420
agtggcagcg ccggagagtt caagaagttc tgtttcaccg tgcgcaagct gatcgggtca 3480
aatgacctgc cggagtacga tttgaaggag gaggcggggc aggctggccc gatcctagtc 3540
atgcgctacc gcaacctgat cgagggcgaa gcatccgccg gttcctaatg tacggagcag 3600
atgctagggc aaattgccct agcaggggaa aaaggtcgaa aaggtctctt tcctgtggat 3660
agcacgtaca ttgggaaccc aaagccgtac attgggaacc ggaacccgta cattgggaac 3720
ccaaagccgt acattgggaa ccggtcacac atgtaagtga ctgatataaa agagaaaaaa 3780
ggcgattttt ccgcctaaaa ctctttaaaa cttattaaaa ctcttaaaac ccgcctggcc 3840
tgtgcataac tgtctggcca gcgcacagcc gaagagctgc aaaaagcgcc tacccttcgg 3900
tcgctgcgct ccctacgccc cgccgcttcg cgtcggccta tcgcggccgc tggccgctca 3960
aaaatggctg gcctacggcc aggcaatcta ccagggcgcg gacaagccgc gccgtcgcca 4020
ctcgaccgcc ggcgcccaca tcaaggcacc ctgcctcgcg cgtttcggtg atgacggtga 4080
aaacctctga cacatgcagc tcccggagac ggtcacagct tgtctgtaag cggatgccgg 4140
gagcagacaa gcccgtcagg gcgcgtcagc gggtgttggc gggtgtcggg gcgcagccat 4200
gacccagtca cgtagcgata gcggagtgta tactggctta actatgcggc atcagagcag 4260
attgtactga gagtgcacca tatgcggtgt gaaataccgc acagatgcgt aaggagaaaa 4320
taccgcatca ggcgctcttc cgcttcctcg ctcactgact cgctgcgctc ggtcgttcgg 4380
ctgcggcgag cggtatcagc tcactcaaag gcggtaatac ggttatccac agaatcaggg 4440
gataacgcag gaaagaacat gtgagcaaaa ggccagcaaa aggccaggaa ccgtaaaaag 4500
gccgcgttgc tggcgttttt ccataggctc cgcccccctg acgagcatca caaaaatcga 4560
cgctcaagtc agaggtggcg aaacccgaca ggactataaa gataccaggc gtttccccct 4620
ggaagctccc tcgtgcgctc tcctgttccg accctgccgc ttaccggata cctgtccgcc 4680
tttctccctt cgggaagcgt ggcgctttct catagctcac gctgtaggta tctcagttcg 4740
gtgtaggtcg ttcgctccaa gctgggctgt gtgcacgaac cccccgttca gcccgaccgc 4800
tgcgccttat ccggtaacta tcgtcttgag tccaacccgg taagacacga cttatcgcca 4860
ctggcagcag ccactggtaa caggattagc agagcgaggt atgtaggcgg tgctacagag 4920
ttcttgaagt ggtggcctaa ctacggctac actagaagga cagtatttgg tatctgcgct 4980
ctgctgaagc cagttacctt cggaaaaaga gttggtagct cttgatccgg caaacaaacc 5040
accgctggta gcggtggttt ttttgtttgc aagcagcaga ttacgcgcag aaaaaaagga 5100
tctcaagaag atcctttgat cttttctacg gggtctgacg ctcagtggaa cgaaaactca 5160
cgttaaggga ttttggtcat gcattctagg tactaaaaca attcatccag taaaatataa 5220
tattttattt tctcccaatc aggcttgatc cccagtaagt caaaaaatag ctcgacatac 5280
tgttcttccc cgatatcctc cctgatcgac cggacgcaga aggcaatgtc ataccacttg 5340
tccgccctgc cgcttctccc aagatcaata aagccactta ctttgccatc tttcacaaag 5400
atgttgctgt ctcccaggtc gccgtgggaa aagacaagtt cctcttcggg cttttccgtc 5460
tttaaaaaat catacagctc gcgcggatct ttaaatggag tgtcttcttc ccagttttcg 5520
caatccacat cggccagatc gttattcagt aagtaatcca attcggctaa gcggctgtct 5580
aagctattcg tatagggaca atccgatatg tcgatggagt gaaagagcct gatgcactcc 5640
gcatacagct cgataatctt ttcagggctt tgttcatctt catactcttc cgagcaaagg 5700
acgccatcgg cctcactcat gagcagattg ctccagccat catgccgttc aaagtgcagg 5760
acctttggaa caggcagctt tccttccagc catagcatca tgtccttttc ccgttccaca 5820
tcataggtgg tccctttata ccggctgtcc gtcattttta aatataggtt ttcattttct 5880
cccaccagct tatatacctt agcaggagac attccttccg tatcttttac gcagcggtat 5940
ttttcgatca gttttttcaa ttccggtgat attctcattt tagccattta ttatttcctt 6000
cctcttttct acagtattta aagatacccc aagaagctaa ttataacaag acgaactcca 6060
attcactgtt ccttgcattc taaaacctta aataccagaa aacagctttt tcaaagttgt 6120
tttcaaagtt ggcgtataac atagtatcga cggagccgat tttgaaaccg cggtgatcac 6180
aggcagcaac gctctgtcat cgttacaatc aacatgctac cctccgcgag atcatccgtg 6240
tttcaaaccc ggcagcttag ttgccgttct tccgaatagc atcggtaaca tgagcaaagt 6300
ctgccgcctt acaacggctc tcccgctgac gccgtcccgg actgatgggc tgcctgtatc 6360
gagtggtgat tttgtgccga gctgccggtc ggggagctgt tggctggctg gtggcaggat 6420
atattgtggt gtaaacaaat tgacgcttag acaacttaat aacacattgc ggacgttttt 6480
aatgtatgct ccaccatgtt ggcgtaaagt cttcactcct ccccctttct ctctagttag 6540
cggagacatg acaaccagtc atccgattag gtttatagtg gcattgcaag cagtcagcaa 6600
atgaataaat gaaagaggca atcttcatgg tcctcttcat cttgtctcac atgcgagttg 6660
attttagacc aacacggtaa ctcaggggat aaaatagatt tgttacaaat ttccaataag 6720
taagattcca tgaaattggt gatagtatat aatgatttta ttgcacaagc tatgcattgc 6780
agctactgat tcaacactat tcagaaaaaa aaagaacaag tgtatttctg gtaaaactgt 6840
tccattcaaa atctagtcca cgactagtcc atgatttggt cgtgtgaaaa caatggatgc 6900
actatatagt ctctagtact attctattgt actaagcact atatatagta ttataaacta 6960
cggtttatgg agtagccagc aagacaataa gttaacaaga aataaattta aagtactaaa 7020
cacaataagc caattagcat ggtgaaatga tgatttgcta tgactaatct acgactaatt 7080
gtgcgacttg ctatttggtc gagtcgtagc cctctagtcg tctgacttga ctgacgttat 7140
gactagtcta cgacttgata acagcgatcc agatgtctta agtgatgagg agaagaaaga 7200
actaccagaa agtaaacctt atatgcatag ttacatacac aggtacactt ccgaaggccc 7260
caatcaatgg aataccatat gctcttatta ggctattata tggttctggg taacaattaa 7320
atatatcatg ggtgtaccgc caatgtgaaa ttgagaactg catacacata gccacattat 7380
aaaatataaa tgcactatgc tcctgatcat ggaatgccaa ccccttatta tcaaacccaa 7440
agaagggaaa tccctttcta tctcaagcat gcacaattac ctttgtttag cataaatcta 7500
tcaaatattg caatgcaaac cttaagcaca gatgtcctcc ctcttaaata ttaatcataa 7560
tcctcagtaa atggacatac agcataaagt actttaaatt accataggtt gaattggaaa 7620
tattcttttt agtagctcac agaaaaatgg gtactaaaac taactattag taaacataaa 7680
agccccttaa tgataggagg gctctacaca agacagtcag tagcatgata accacctaca 7740
atgttgttcc tacaaataaa aatactgtag caatctctta ctaagttaaa acatactgag 7800
gttctagggt ttaaccataa gtaattagaa tatcaaaata gctcaagatt agagaaggtc 7860
ctacagaaaa acacggttat ctgcttctca aatggcctag ctacaccggg cactagcagg 7920
atcttaaaca gcactaaaat aagtatctcc cttggtcatc aaatcgaaaa gaaaatccta 7980
cagagtccac gcctttcctt ccccccacta attaacgaaa agaaacgcag agttccaatt 8040
aaggagaaag agatacgggg tacaacaaac atcgcattcg tctcgtgcta gggttttcgg 8100
gaggcgggtc tagggttgag gcaaaaaggg ggagggaatt gagcaggggg ttaccgcggt 8160
agtcgacgcc ggagttgagc ttgacgacga cggggcgccc cctgatggac ttgaggaagt 8220
cggagggcgt cttcaccgcc ccgccgccgc cgccaccgcc gccgccgccc gagccggact 8280
tctcgccgcc actgctcatc ttgcgctgcg tttgtgcggg tgcgggtgcg ggtgctagac 8340
tgctaggtct cgcggttgca tccgcatccg actttgagat cgatttttta tcgggttctg 8400
taccctccac ccgttattgg gactgaccca cctgtcatcc tcatccaatc gactgacacg 8460
cgggcccaga tcgaccccga cgtggctgtg tgtcatccta tcccaccgac atatggggcc 8520
cactgtgacg tggccccaca cgatcccatc cgagccacac atcgcctcac gctgcgtcac 8580
cgcgcgcgga caaaacaccc acacccccac actctccacc cctctctccc tctcgcccaa 8640
acccagaaac cctcgccgcc gccgccgccg ccaccaccca ccatggctac gaccgccgcg 8700
gccgcggccg ccgccctgtc cgccgccgcg acggccaaga ccggccgtaa gaaccaccag 8760
cgacaccacg tccttcccgc tcgaggccgg gtgggggcgg cggcggtcag gtgctcggcg 8820
gtgtccccgg tcaccccgcc gtccccggcg ccgccggcca cgccgctccg gccgtggggg 8880
ccggccgagc cccgcaaggg cgcggacatc ctcgtggagg cgctggagcg gtgcggcgtc 8940
agcgacgtgt tcgcctaccc gggcgccgcg tccatggaga tccaccaggc gctgacgcgc 9000
tccccggtca tcaccaacca cctcttccgc cacgagcagg gcgaggcgtt cgcggcgtcc 9060
gggtacgcgc gcgcgtccgg ccgcgtcggg gtctgcgtcg ccacctccgg ccccggggca 9120
accaacctcg tgtccgcgct cgccgacgcg ctgctcgact ccgtcccgat ggtcgccatc 9180
acgggccagg tcccccgccg catgatcggc accgacgcct tccaggagac gcccatagtc 9240
gaggtcaccc gctccatcac caagcacaat taccttgtcc ttgatgtgga ggacatcccc 9300
cgcgtcatac aggaagcctt cttcctcgcg tcctcgggcc gtcctggccc ggtgctggtc 9360
gacatcccca aggacatcca gcagcagatg gccgtgccgg tctgggacac ctcgatgaat 9420
ctaccagggt acatcgcacg cctgcccaag ccacccgcga cagaattgct tgagcaggtc 9480
ttgcgtctgg ttggcgagtc acggcgcccg attctctatg tcggtggtgg ctgctctgca 9540
tctggtgacg aattgcgctg gtttgttgag ctgactggta tcccagttac aaccactctg 9600
atgggcctcg gcaatttccc cagtgacgac ccgttgtccc tgcgcatgct tgggatgcat 9660
ggcacggtgt acgcaaatta tgccgtggat aaggctgacc tgttgcttgc gtttggtgtg 9720
cggtttgatg atcgtgtgac agggaaaatt gaggcttttg caagcagggc caagattgtg 9780
cacattgaca ttgatccagc agagattgga aagaacaagc aaccacatgt gtcaatttgc 9840
gcagatgtta agcttgcttt acagggcttg aatgctctgc tacaacagag cacaacaaag 9900
acaagttctg attttagtgc atggcacaat gagttggacc agcagaagag ggagtttcct 9960
ctggggtaca aaacttttgg tgaagagatc ccaccgcaat atgccattca ggtgctggat 10020
gagctgacga aaggtgaggc aatcatcgct actggtgttg ggcagcacca gatgtgggcg 10080
gcacaatatt acacctacaa gcggccacgg cagtggctgt cttcggctgg tctgggcgca 10140
atgggatttg ggctgcctgc tgcagctggt gcttctgtgg ctaacccagg tgtcacagtt 10200
gttgatattg atggggatgg tagcttcctc atgaacattc aggagctggc attgatccgc 10260
attgagaacc tccctgtgaa ggtgatggtg ttgaacaacc aacatttggg tatggtggtg 10320
caattggagg ataggtttta caaggcgaat agggcgcata catacttggg caacccggaa 10380
tgtgagagcg agatatatcc agattttgtg actattgcta aggggttcaa tattcctgca 10440
gtccgtgtaa caaagaagag tgaagtccgt gccgccatca agaagatgct cgagactcca 10500
gggccatact tgttggatat catcgtcccg caccaggagc atgtgctgcc tatgatccca 10560
attgggggcg cattcaagga catgatcctg gatggtgatg gcaggactgt gtattaatct 10620
agagtcctca gccatagagc tgctgctgtt ctagggttca caagtctgcc tatttgtctt 10680
ccccaatgga gctatggttg tctggtctgg tccttggtcg tgtcccgttt cattgtgtac 10740
tatttacctg taatgtgtat ccttaagtct ggtttgatgg tgtctgaaac gttttgctgt 10800
ggtagagcag catggaagaa ctataatgaa taagtgatcc ctaatcattg tgtccaaatt 10860
ttgcttctgc tatacccttt tgtgctgttt cttatgtttt gcttaaaaat ttgatctgac 10920
<210>5
<211>52
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>5
cgtttttaat gtatgctcca ccatgttggc gtaaagtctt cactcctccc cc 52
<210>6
<211>24
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>6
cgtagccatg gtgggtggtg gcgg 24
<210>7
<211>25
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>7
cacccaccat ggctacgacc gccgc 25
<210>8
<211>38
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>8
ggctgaggac tctagattaa tacacagtcc tgccatca 38
<210>9
<211>33
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>9
tgtattaatc tagagtcctc agccatagag ctg 33
<210>10
<211>48
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>10
tgcccgggcc tgcaggacaa atttgtttgt cagatcaaat ttttaagc 48
<210>11
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>11
gggccatact tgttggatat cat 23
<210>12
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>12
ttgttcatgg cgtaatgtct cc 22
<210>13
<211>19
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>13
<210>14
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>14
gacaaatttg tttgtcagat caa 23
Claims (10)
1. A rice A L S mutein characterized in that the A L S mutein has amino acid mutations at positions 95, 548 and 627 relative to the wild-type A L S protein.
2. The A L S mutein of claim 1, wherein the A L S mutein is mutated from Gly to Ala at position 95, Trp to L eu at position 548, Ser to Ile at position 627, relative to the wild-type A L S protein;
preferably, the a L S mutein has the amino acid sequence of (1) or (2) below:
(1) an amino acid sequence shown as SEQ ID NO. 1;
(2) the amino acid sequence of the A L S mutant protein which is obtained by substituting, inserting or deleting one or more amino acids in the amino acid sequence shown as SEQ ID NO.1 and can enable plants to have the resistance of A L S inhibitor herbicides.
3. A nucleic acid encoding the a L S mutein of claim 1 or 2.
4. A biological material which is an expression cassette, vector, host cell or transgenic plant cell line comprising a nucleic acid according to claim 3.
5. Use of the a L S mutein of claim 1 or 2 or the nucleic acid of claim 3 or the biological material of claim 4 for any one of the following:
(1) use in conferring resistance to an a L S inhibitor herbicide or increasing resistance to an a L S inhibitor herbicide in a plant;
(2) the application in preparing transgenic plants;
(3) the application in the improvement of plant germplasm resources;
(4) the application of the gene expression vector in the selection of plant genetic transformation or the construction of plant genetic transformation selection vectors.
6. A plant transgenic screening expression cassette, which is characterized in that a plant endogenous gene is used as a screening marker, and the plant endogenous gene is an A L S mutant gene;
preferably, the A L S mutant gene is a rice A L S mutant gene;
more preferably, the protein encoded by the rice A L S mutant gene is the A L S mutant protein of claim 1 or 2.
7. The plant transgene screening expression cassette of claim 6, further comprising a promoter and a terminator for initiating and terminating transcription of the a L S mutant gene;
the promoter is a rice A L S gene promoter, a Ubi promoter, an Actin promoter, a Rubisco small subunit promoter or a Cab promoter of rice or corn;
the terminator is a rice A L S gene terminator or a Ubi terminator;
preferably, the promoter is a rice A L S gene promoter, and the terminator is a rice Ubi terminator;
more preferably, the nucleotide sequence of the expression cassette is shown in SEQ ID NO. 3.
8. A plant genetic transformation screening vector comprising the plant transgene screening expression cassette of claim 6 or 7;
preferably, the plant genetic transformation screening vector is a plant binary expression vector, and can enter the vector for genetic transformation by cloning other expression cassettes;
the other expression cassette is an expression cassette other than the plant transgene screening expression cassette of claim 6 or 7;
more preferably, the nucleotide sequence of the plant genetic transformation screening vector is shown in SEQ ID NO. 4.
9. Use of the plant transgene selection expression cassette of claim 6 or 7 or the plant genetic transformation selection vector of claim 8 in genetic transformation of plants.
10. The application according to claim 9, wherein the application comprises: after the plant transgenic screening expression cassette or the plant genetic transformation screening vector is transferred into plant callus, a screening culture medium containing herbicide is adopted for resistance screening in a screening stage;
preferably, the screening culture medium contains 0.25-1 mu mol/L Bispyribac-sodium, 200-1000 mu g/L Mexican-P or 300-1000 mu g/L imazethapyr;
and/or, the application comprises: in the differentiation stage after the plant transgenic screening expression cassette or the plant genetic transformation screening carrier is transferred into the plant callus, a differentiation culture medium containing herbicide is adopted for differentiation culture;
preferably, the differentiation medium contains 0.05-1 mu mol/L Bispyribac-sodium, 25-1000 mu g/L Mexican-P or 25-1000 mu g/L imazethapyr;
and/or the presence of a gas in the gas,
the application comprises the following steps: in the rooting stage after the plant transgenic screening expression box or the plant genetic transformation screening vector is transferred into the plant callus, a rooting culture medium containing herbicide is adopted for rooting culture;
preferably, the rooting medium contains 0.05-10 mu mol/L Bispyribac-sodium, 25-1000 mu g/L Mexican-P or 25-1000 mu g/L imazethapyr.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010379281.1A CN111411098B (en) | 2020-05-07 | 2020-05-07 | Rice ALS mutant gene, plant transgenic screening vector pCALSm2 containing gene and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010379281.1A CN111411098B (en) | 2020-05-07 | 2020-05-07 | Rice ALS mutant gene, plant transgenic screening vector pCALSm2 containing gene and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111411098A true CN111411098A (en) | 2020-07-14 |
| CN111411098B CN111411098B (en) | 2022-03-04 |
Family
ID=71487176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010379281.1A Active CN111411098B (en) | 2020-05-07 | 2020-05-07 | Rice ALS mutant gene, plant transgenic screening vector pCALSm2 containing gene and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111411098B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115851650A (en) * | 2022-09-06 | 2023-03-28 | 海南波莲科技有限公司 | A kind of ALS mutant protein and its coding gene and application |
| CN115851652A (en) * | 2022-09-06 | 2023-03-28 | 海南波莲科技有限公司 | Rice ALS mutant gene and encoding protein and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0615947A2 (en) * | 2005-09-07 | 2011-05-31 | Monsanto Technology Llc | agronomically high soybeans with high beta-conglycinin content |
| WO2016007948A1 (en) * | 2014-07-11 | 2016-01-14 | Pioneer Hi-Bred International, Inc. | Agronomic trait modification using guide rna/cas endonuclease systems and methods of use |
| CN106434708A (en) * | 2016-08-24 | 2017-02-22 | 海南波莲水稻基因科技有限公司 | Rice MSP1 gene mutant, and molecular identification method and application thereof |
| CN107090447A (en) * | 2017-06-23 | 2017-08-25 | 江苏省农业科学院 | Make plant that there is paddy rice ALS muteins, gene and its application of Herbicid resistant |
| CN107964543A (en) * | 2017-12-25 | 2018-04-27 | 江苏省农业科学院 | Rice herbicide resistance ALS muteins, nucleic acid and its application |
-
2020
- 2020-05-07 CN CN202010379281.1A patent/CN111411098B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0615947A2 (en) * | 2005-09-07 | 2011-05-31 | Monsanto Technology Llc | agronomically high soybeans with high beta-conglycinin content |
| WO2016007948A1 (en) * | 2014-07-11 | 2016-01-14 | Pioneer Hi-Bred International, Inc. | Agronomic trait modification using guide rna/cas endonuclease systems and methods of use |
| CN106434708A (en) * | 2016-08-24 | 2017-02-22 | 海南波莲水稻基因科技有限公司 | Rice MSP1 gene mutant, and molecular identification method and application thereof |
| CN107090447A (en) * | 2017-06-23 | 2017-08-25 | 江苏省农业科学院 | Make plant that there is paddy rice ALS muteins, gene and its application of Herbicid resistant |
| CN107964543A (en) * | 2017-12-25 | 2018-04-27 | 江苏省农业科学院 | Rice herbicide resistance ALS muteins, nucleic acid and its application |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115851650A (en) * | 2022-09-06 | 2023-03-28 | 海南波莲科技有限公司 | A kind of ALS mutant protein and its coding gene and application |
| CN115851652A (en) * | 2022-09-06 | 2023-03-28 | 海南波莲科技有限公司 | Rice ALS mutant gene and encoding protein and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111411098B (en) | 2022-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111593031B (en) | Rice ALS mutant gene, plant transgenic screening vector pCALSm3 containing the gene and its application | |
| CN107043779B (en) | Application of a CRISPR/nCas9-mediated site-directed base replacement in plants | |
| KR101331677B1 (en) | Stress resistant plants | |
| CN110904071B (en) | Application of RAF49 protein and encoding gene thereof in regulation and control of plant drought resistance | |
| CA2521729A1 (en) | Methods and means for increasing the tolerance of plants to stress conditions | |
| CN112279903B (en) | A gene for improving rice blast resistance at ear stage and its use | |
| CN106929532B (en) | Artificially creating male sterile line of maize and efficient transfer method | |
| CN113151200A (en) | Plant ACCase mutant protein and gene sequence and application thereof | |
| CN111411098B (en) | Rice ALS mutant gene, plant transgenic screening vector pCALSm2 containing gene and application thereof | |
| CN111018959A (en) | Application of BMDR protein and its encoding gene in regulating plant drought resistance | |
| CN113201557A (en) | Method for guiding editing system to mediate crops to generate endogenous herbicide resistance | |
| RU2681162C1 (en) | Herbicides resistance protein encoding genes thereof and application thereof | |
| CN112553222B (en) | Hot pepper heat-resistant gene and application thereof | |
| CN107417779B (en) | A plant aluminum tolerance-related protein GmGRPL and its encoding gene and application | |
| CN110229843B (en) | Upland cotton transformation event 19PFA1-135-17 and its specific identification method | |
| CN111471684B (en) | Plant constitutive promoter ALSpro and its application | |
| CN105255859B (en) | A kind of method to improve plant's ability to tolerate abiotic stress | |
| CN111560396B (en) | Plant transgenic screening vector pCALSm1 and application thereof | |
| US20170303488A1 (en) | Chlorella variabilis-derived phosphomannose isomerase gene and application thereof | |
| CN110564752B (en) | Application of differential surrogate technology in enrichment of C·T base substitution cells | |
| CN112812162A (en) | Rice resistance related gene and application thereof | |
| CN113185590B (en) | Gene for regulating early heading and flowering of rice and application thereof | |
| CN114163509B (en) | PAO gene of Chinese cabbage and application thereof in regulating and controlling green-keeping character of plants | |
| JP2004329210A (en) | Genes that confer salt stress tolerance | |
| US9365862B1 (en) | Herbicide resistant sorghum mutants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |